☰

Joel S. Parker, Ph.D. - Publications

Affiliations: 
2010 Bioinformatics & Computational Biology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Bioinformatics, Genetics, Oncology
Tree Info Similar researchers PubMed Report error

241/450 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Han YJ, Liu S, Hardeman A, Rajagopal PS, Mueller J, Khramtsova G, Sanni A, Ajani MA, Clayton W, Hurley IW, Yoshimatsu TF, Zheng Y, Parker J, Perou CM, Olopade OI. The VEGF-Hypoxia Signature is Upregulated in Basal like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 38564595 DOI: 10.1158/1078-0432.CCR-23-1526  0.526
2024 Conte B, Brasó-Maristany F, Hernández AR, Pascual T, Villacampa G, Schettini F, Vidal Losada MJ, Seguí E, Angelats L, Garcia-Fructuoso I, Gómez-Bravo R, Lorman-Carbó N, Paré L, Marín-Aguilera M, Martínez-Sáez O, ... ... Parker JS, et al. A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies. Ebiomedicine. 102: 105043. PMID 38447275 DOI: 10.1016/j.ebiom.2024.105043  0.559
2023 Rediti M, Fernandez-Martinez A, Venet D, Rothé F, Hoadley KA, Parker JS, Singh B, Campbell JD, Ballman KV, Hillman DW, Winer EP, El-Abed S, Piccart M, Di Cosimo S, Symmans WF, et al. Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials. Nature Communications. 14: 7053. PMID 37923752 DOI: 10.1038/s41467-023-42635-2  0.708
2023 Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 4192-4199. PMID 37672882 DOI: 10.1200/JCO.22.02511  0.553
2023 Tovey H, Sipos O, Parker JS, Hoadley KA, Quist J, Kernaghan S, Kilburn L, Salgado R, Loi S, Kennedy RD, Roxanis I, Gazinska P, Pinder SE, Bliss J, Perou CM, et al. Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF15. PMID 37574209 DOI: 10.1158/1078-0432.CCR-23-0370  0.668
2023 Waks AG, Ogayo ER, Paré L, Marín-Aguilera M, Brasó-Maristany F, Galván P, Castillo O, Martínez-Sáez O, Vivancos A, Villagrasa P, Villacampa G, Tarantino P, Desai N, Guerriero J, Metzger O, ... ... Parker JS, et al. Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab. Jama Oncology. PMID 37103927 DOI: 10.1001/jamaoncol.2023.0181  0.524
2023 Bueno-Muiño C, Echavarría I, López-Tarruella S, Roche-Molina M, Del Monte-Millán M, Massarrah T, Jerez Y, Ayala de la Peña F, García-Sáenz JÁ, Moreno F, Rodríguez-Lescure Á, Malón-Giménez D, Ballesteros García AI, Marín-Aguilera M, Galván P, ... ... Parker JS, et al. Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab. Jama Oncology. PMID 37103916 DOI: 10.1001/jamaoncol.2023.0187  0.547
2023 Prat A, Brasó-Maristany F, Martínez-Sáez O, Sanfeliu E, Xia Y, Bellet M, Galván P, Martínez D, Pascual T, Marín-Aguilera M, Rodríguez A, Chic N, Adamo B, Paré L, Vidal M, ... ... Parker JS, et al. Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer. Nature Communications. 14: 1157. PMID 36859416 DOI: 10.1038/s41467-023-36801-9  0.582
2023 Price BA, Marron JS, Mose LE, Perou CM, Parker JS. Translating transcriptomic findings from cancer model systems to humans through joint dimension reduction. Communications Biology. 6: 179. PMID 36797360 DOI: 10.1038/s42003-023-04529-3  0.457
2022 Garcia-Recio S, Hinoue T, Wheeler GL, Kelly BJ, Garrido-Castro AC, Pascual T, De Cubas AA, Xia Y, Felsheim BM, McClure MB, Rajkovic A, Karaesmen E, Smith MA, Fan C, Ericsson PIG, ... ... Parker JS, et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nature Cancer. PMID 36585450 DOI: 10.1038/s43018-022-00491-x  0.719
2022 Brasó-Maristany F, Griguolo G, Chic N, Pascual T, Paré L, Maues J, Galván P, Dieci MV, Miglietta F, Giarratano T, Martínez-Sáez O, Marín-Aguilera M, Schettini F, Conte B, Angelats L, ... ... Parker JS, et al. HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute. PMID 36576009 DOI: 10.1093/jnci/djac227  0.488
2022 Guarneri V, Bras-Maristany F, Dieci MV, Griguolo G, Par L, Mar Ín-Aguilera M, Miglietta F, Bottosso M, Giorgi CA, Blasco P, Castillo O, Galv N P, Vivancos A, Villagrasa P, Parker JS, et al. HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial. Ebiomedicine. 85: 104320. PMID 36374768 DOI: 10.1016/j.ebiom.2022.104320  0.563
2022 Routh ED, Van Swearingen AED, Sambade MJ, Vensko S, McClure MB, Woodcock MG, Chai S, Cuaboy LA, Wheless A, Garrett A, Carey LA, Hoyle AP, Parker JS, Vincent BG, Anders CK. Comprehensive Analysis of the Immunogenomics of Triple-Negative Breast Cancer Brain Metastases From LCCC1419. Frontiers in Oncology. 12: 818693. PMID 35992833 DOI: 10.3389/fonc.2022.818693  0.408
2022 Kelly MR, Wisniewska K, Regner MJ, Lewis MW, Perreault AA, Davis ES, Phanstiel DH, Parker JS, Franco HL. A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer. Nature Communications. 13: 4247. PMID 35869079 DOI: 10.1038/s41467-022-31919-8  0.351
2022 Xia Y, He X, Renshaw L, Martinez-Perez C, Kay C, Gray M, Meehan J, Parker JS, Perou CM, Carey LA, Dixon JM, Turnbull A. Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35653148 DOI: 10.1158/1078-0432.CCR-21-3189  0.562
2022 Nishijima TF, Kardos J, Chai S, Smith CC, Bortone DS, Selitsky SR, Parker JS, Sanoff HK, Lee MS, Vincent BG. Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer. Jco Precision Oncology. 1: 1-10. PMID 35172495 DOI: 10.1200/PO.17.00047  0.332
2022 Shepherd JH, Ballman K, Polley MC, Campbell JD, Fan C, Selitsky S, Fernandez-Martinez A, Parker JS, Hoadley KA, Hu Z, Li Y, Soloway MG, Spears PA, Singh B, Tolaney SM, et al. CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101506. PMID 35044810 DOI: 10.1200/JCO.21.01506  0.649
2022 Prat A, Guarneri V, Pascual T, Brasó-Maristany F, Sanfeliu E, Paré L, Schettini F, Martínez D, Jares P, Griguolo G, Dieci MV, Cortés J, Llombart-Cussac A, Conte B, Marín-Aguilera M, ... ... Parker JS, et al. Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer. Ebiomedicine. 75: 103801. PMID 34990895 DOI: 10.1016/j.ebiom.2021.103801  0.54
2021 Bergamino Sirvén MA, Morani G, Parker JS, Schuster EF, Ferreira Leal M, López-Knowles E, Tovey H, Bliss JM, Robertson JF, Smith IE, Dowsett M, Cheang MCU. Impact of duration of neoadjuvant aromatase inhibitors on molecular expression profiles in estrogen receptor positive breast cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34965950 DOI: 10.1158/1078-0432.CCR-21-2718  0.34
2021 Regner MJ, Wisniewska K, Garcia-Recio S, Thennavan A, Mendez-Giraldez R, Malladi VS, Hawkins G, Parker JS, Perou CM, Bae-Jump VL, Franco HL. A multi-omic single-cell landscape of human gynecologic malignancies. Molecular Cell. 81: 4924-4941.e10. PMID 34739872 DOI: 10.1016/j.molcel.2021.10.013  0.506
2021 Little P, Jo H, Hoyle A, Mazul A, Zhao X, Salazar AH, Farquhar D, Sheth S, Masood M, Hayward MC, Parker JS, Hoadley KA, Zevallos J, Hayes DN. UNMASC: tumor-only variant calling with unmatched normal controls. Nar Cancer. 3: zcab040. PMID 34632388 DOI: 10.1093/narcan/zcab040  0.541
2021 Jariwala N, Mehta GA, Bhatt V, Hussein S, Parker KA, Yunus N, Parker JS, Guo JY, Gatza ML. CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer. Nar Cancer. 3: zcab035. PMID 34514415 DOI: 10.1093/narcan/zcab035  0.415
2021 Angus SP, Stuhlmiller TJ, Mehta G, Bevill SM, Goulet DR, Olivares-Quintero JF, East MP, Tanioka M, Zawistowski JS, Singh D, Sciaky N, Chen X, He X, Rashid NU, Chollet-Hinton L, ... ... Parker JS, et al. FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036. Npj Breast Cancer. 7: 51. PMID 33980863 DOI: 10.1038/s41523-021-00258-0  0.512
2021 Morton LM, Karyadi DM, Stewart C, Bogdanova TI, Dawson ET, Steinberg MK, Dai J, Hartley SW, Schonfeld SJ, Sampson JN, Maruvka Y, Kapoor V, Ramsden DA, Carvajal-Garcia J, Perou CM, ... Parker JS, et al. Radiation-related genomic profile of papillary thyroid cancer after the Chernobyl accident. Science (New York, N.Y.). PMID 33888599 DOI: 10.1126/science.abg2538  0.378
2021 Lou J, Yang Y, Gu Q, Price BA, Qiu Y, Fedoriw Y, Desai S, Mose LE, Chen B, Tateishi S, Parker JS, Vaziri C, Wu D. Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors . Nar Cancer. 3: zcaa037. PMID 33447826 DOI: 10.1093/narcan/zcaa037  0.32
2020 Kardos J, Rose TL, Manocha U, Wobker SE, Damrauer JS, Bivalaqua TJ, Kates M, Moore KJ, Parker JS, Kim WY. Development and validation of a NanoString BASE47 bladder cancer gene classifier. Plos One. 15: e0243935. PMID 33332422 DOI: 10.1371/journal.pone.0243935  0.311
2020 Prat A, Guarneri V, Paré L, Griguolo G, Pascual T, Dieci MV, Chic N, González-Farré B, Frassoldati A, Sanfeliu E, Cejalvo JM, Muñoz M, Bisagni G, Brasó-Maristany F, Urso L, ... ... Parker JS, et al. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation. The Lancet. Oncology. 21: 1455-1464. PMID 33152285 DOI: 10.1016/S1470-2045(20)30450-2  0.527
2020 Fernandez-Martinez A, Krop IE, Hillman DW, Polley MY, Parker JS, Huebner L, Hoadley KA, Shepherd J, Tolaney S, Henry NL, Dang C, Harris L, Berry D, Hahn O, Hudis C, et al. Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001276. PMID 33095682 DOI: 10.1200/JCO.20.01276  0.655
2020 Prat A, Tsai YH, Pascual T, Paré L, Adamo B, Vidal M, Brasó-Maristany F, Galván P, Brase JC, Rodrik-Outmezguine V, Johnston SRD, Ciruelos EM, Parker JS. A prognostic model based on PAM50 and clinical variables (PAM50MET) for metastatic hormone-receptor-positive HER2-negative breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32962980 DOI: 10.1158/1078-0432.CCR-20-2793  0.331
2020 Innocenti F, Sibley AB, Patil SA, Etheridge AS, Jiang C, Ou FS, Howell S, Plummer SJ, Casey G, Bertagnolli MM, McLeod HL, Auman JT, Blanke CD, Furukawa Y, Venook AP, ... ... Parker JS, et al. Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32958699 DOI: 10.1158/1078-0432.Ccr-20-2021  0.371
2020 Gorlov IP, Amos CI, Tsavachidis S, Begg C, Hernando E, Cheng C, Shen R, Orlow I, Luo L, Ernstoff MS, Parker J, Thomas NE, Gorlova OY, Berwick M. Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma. Human Mutation. PMID 32643855 DOI: 10.1002/Humu.24078  0.362
2020 Lundberg A, Lindström LS, Parker JS, Löverli E, Perou CM, Bergh J, Tobin NP. A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels. Oncogene. PMID 32581248 DOI: 10.1038/S41388-020-1367-4  0.516
2020 Garcia-Recio S, Thennavan A, East MP, Parker JS, Cejalvo JM, Garay JP, Hollern DP, He X, Mott KR, Galván P, Fan C, Selitsky SR, Coffey AR, Marron D, Brasó-Maristany F, et al. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease. The Journal of Clinical Investigation. PMID 32573490 DOI: 10.1172/Jci130323  0.641
2020 Fagan-Solis KD, Simpson DA, Kumar RJ, Martelotto LG, Mose LE, Rashid NU, Ho AY, Powell SN, Wen YH, Parker JS, Reis-Filho JS, Petrini JHJ, Gupta GP. A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability. Cell Reports. 30: 1385-1399.e7. PMID 32023457 DOI: 10.1016/J.Celrep.2020.01.020  0.416
2020 Selitsky SR, Marron D, Hollern D, Mose LE, Hoadley KA, Jones C, Parker JS, Dittmer DP, Perou CM. Virus expression detection reveals RNA-sequencing contamination in TCGA. Bmc Genomics. 21: 79. PMID 31992194 DOI: 10.1186/S12864-020-6483-6  0.629
2020 Risueno A, Hagner PR, Towfic F, Fontanillo C, Djebbari A, Parker JS, Drew C, Nowakowski GS, Maurer MJ, Cerhan JR, Wei X, Ren Y, Lee CW, Couto S, Wang M, et al. Leveraging Gene Expression Subgroups to Classify DLBCL Patients and Enrich for Clinical Benefit to a Novel Agent. Blood. PMID 31977005 DOI: 10.1182/Blood.2019002414  0.411
2020 Innocenti F, Selitsky SR, Parker JS, Auman JT, Hammond K, Patil SA, Sanoff HK, Lee MS. Association of KRAS and BRAF mutations with progression-free survival (PFS) with second-line FOLFIRI +/- regorafenib in metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 38: 196-196. DOI: 10.1200/Jco.2020.38.4_Suppl.196  0.318
2020 Tovey H, Parker JS, Hoadley KA, Kennedy RD, Sipos O, Kilburn L, Kernaghan S, Gazinska P, Haider S, Pinder SE, Bliss J, Perou CM, Grigoriadis A, Tutt A, Cheang MCU. Evaluation of DNA repair biology signatures to predict specific carboplatin (C) versus docetaxel (D) benefit in advanced triple-negative breast cancer (aTNBC). Journal of Clinical Oncology. 38: 1074-1074. DOI: 10.1200/Jco.2020.38.15_Suppl.1074  0.665
2020 Xia Y, Fan C, Hoadley KA, Parker JS, Perou CM. Abstract P4-05-12: Genetic determinants of the molecular portraits of epithelial cancers Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-05-12  0.74
2020 King TA, Liu MC, McClure MB, Hinoue T, Kelly BJ, Creighton CJ, Bowen J, Leraas K, Burns RT, Coppens S, Rezk S, Garrett AL, Balko JM, Parker JS, Park BH, et al. Abstract GS3-08: Multiplatform analysis of matched primary and metastatic breast tumors from the AURORA US Network Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Gs3-08  0.748
2020 Lee MS, Keku TO, McCoy A, Selitsky SR, Parker J, Auman T, Hammond K, Patil SA, Manyam G, Kopetz S, Sanoff HK, Innocenti F. Abstract A03: Association of Fusobacterium nucleatum (F. nucleatum) with progression-free survival (PFS) and overall survival (OS) with 2nd-line FOLFIRI +/- regorafenib in metastatic colorectal cancer (mCRC) Cancer Research. 80. DOI: 10.1158/1538-7445.Mvc2020-A03  0.317
2019 Xia Y, Fan C, Hoadley KA, Parker JS, Perou CM. Genetic determinants of the molecular portraits of epithelial cancers. Nature Communications. 10: 5666. PMID 31827079 DOI: 10.1038/S41467-019-13588-2  0.732
2019 Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, He X, Garay JP, Carey-Ewend K, Marron D, Ford J, Liu S, Vick SC, Martin M, Parker JS, et al. B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. Cell. 179: 1191-1206.e21. PMID 31730857 DOI: 10.1016/J.Cell.2019.10.028  0.574
2019 Feng W, Simpson DA, Carvajal-Garcia J, Price BA, Kumar RJ, Mose LE, Wood RD, Rashid N, Purvis JE, Parker JS, Ramsden DA, Gupta GP. Genetic determinants of cellular addiction to DNA polymerase theta. Nature Communications. 10: 4286. PMID 31537809 DOI: 10.1038/S41467-019-12234-1  0.387
2019 Leslie PL, Chao YL, Tsai YH, Ghosh SK, Porrello A, Van Swearingen AED, Harrison EB, Cooley BC, Parker JS, Carey LA, Pecot CV. Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes. Nature Communications. 10: 4192. PMID 31519896 DOI: 10.1038/S41467-019-12222-5  0.436
2019 Smith CC, Chai S, Washington AR, Lee SJ, Landoni E, Field K, Garness J, Bixby LM, Selitsky SR, Parker JS, Savoldo B, Serody JS, Vincent BG. Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes. Cancer Immunology Research. PMID 31515258 DOI: 10.1158/2326-6066.Cir-19-0155  0.364
2019 Barrow MA, Martin ME, Coffey A, Andrews PL, Jones GS, Reaves DK, Parker JS, Troester MA, Fleming JM. A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer. Breast Cancer Research : Bcr. 21: 105. PMID 31511085 DOI: 10.1186/S13058-019-1191-3  0.485
2019 Prat A, Parker JS. Standardized versus research-based PAM50 intrinsic subtyping of breast cancer. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. PMID 31435878 DOI: 10.1007/S12094-019-02203-X  0.446
2019 Gao GF, Parker JS, Reynolds SM, Silva TC, Wang LB, Zhou W, Akbani R, Bailey M, Balu S, Berman BP, Brooks D, Chen H, Cherniack AD, Demchok JA, Ding L, et al. Before and After: Comparison of Legacy and Harmonized TCGA Genomic Data Commons' Data. Cell Systems. 9: 24-34.e10. PMID 31344359 DOI: 10.1016/J.Cels.2019.06.006  0.577
2019 Picornell AC, Echavarria I, Alvarez E, López-Tarruella S, Jerez Y, Hoadley K, Parker JS, Del Monte-Millán M, Ramos-Medina R, Gayarre J, Ocaña I, Cebollero M, Massarrah T, Moreno F, García Saenz JA, et al. Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series. Bmc Genomics. 20: 452. PMID 31159741 DOI: 10.1186/S12864-019-5849-0  0.724
2019 Selitsky SR, Mose LE, Smith CC, Chai S, Hoadley KA, Dittmer DP, Moschos SJ, Parker JS, Vincent BG. Prognostic value of B cells in cutaneous melanoma. Genome Medicine. 11: 36. PMID 31138334 DOI: 10.1186/S13073-019-0647-5  0.583
2019 Prat A, Pascual T, De Angelis C, Gutierrez C, Llombart-Cussac A, Wang T, Cortés J, Rexer B, Paré L, Forero A, Wolff AC, Morales S, Adamo B, Brasó-Maristany F, Vidal M, ... ... Parker JS, et al. HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade. Journal of the National Cancer Institute. PMID 31037288 DOI: 10.1093/Jnci/Djz042  0.476
2019 Vora NL, Parker JS, Mieckowski PA, Smeester L, Fry RC, Boggess KA. RNA-Sequencing of Umbilical Cord Blood to Investigate Spontaneous Preterm Birth: A Pilot Study. Ajp Reports. 9: e60-e66. PMID 30854245 DOI: 10.1055/S-0039-1678717  0.319
2019 Wong KY, Fan C, Tanioka M, Parker JS, Nobel AB, Zeng D, Lin DY, Perou CM. I-Boost: an integrative boosting approach for predicting survival time with multiple genomics platforms. Genome Biology. 20: 52. PMID 30845957 DOI: 10.1186/S13059-019-1640-4  0.522
2019 Alzubi MA, Turner TH, Olex AL, Sohal SS, Tobin NP, Recio SG, Bergh J, Hatschek T, Parker JS, Sartorius CA, Perou CM, Dozmorov MG, Harrell JC. Separation of breast cancer and organ microenvironment transcriptomes in metastases. Breast Cancer Research : Bcr. 21: 36. PMID 30841919 DOI: 10.1186/S13058-019-1123-2  0.54
2019 Mose LE, Perou CM, Parker JS. Improved Indel Detection in DNA and RNA via Realignment with ABRA2. Bioinformatics (Oxford, England). PMID 30649250 DOI: 10.1093/Bioinformatics/Btz033  0.482
2019 Lee MS, Selitsky SR, Parker JS, Auman JT, Wu Y, Hammond K, O'Neil B, Sanoff HK, Innocenti F. Association of consensus molecular subtypes (CMS) with time to progression (TTP), progression free survival (PFS), and overall survival (OS) with second-line FOLFIRI ± regorafenib in metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 37: 597-597. DOI: 10.1200/Jco.2019.37.4_Suppl.597  0.322
2019 Beaty BT, Gupta G, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson JE, Patel SA, Zanation AM, Hackman T, Thorp B, Blumberg J, Patel S, Weissler MC, Yarbrough WG, Sheets NC, ... Parker JS, et al. PIK3CA mutation as a prognostic factor in HPV-associated oropharynx cancer. Journal of Clinical Oncology. 37: 6011-6011. DOI: 10.1200/Jco.2019.37.15_Suppl.6011  0.32
2019 Fernandez-Martinez A, Tanioka M, Fan C, Parker JS, Hoadley KA, Krop IE, Cortes J, Llombart Cussac A, Nuciforo P, Galván P, Pascual T, Partridge AH, Prat A, Carey LA, Perou CM. Genomic-based predictive biomarkers to anti-HER2 therapies: A combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials. Journal of Clinical Oncology. 37: 571-571. DOI: 10.1200/Jco.2019.37.15_Suppl.571  0.702
2019 Hollern D, Xu N, Mott K, He X, Carey-Ewend K, Marron D, Ford J, Parker J, Vincent B, Serody J, Perou C. Abstract GS1-05: Apobec3 induced mutagenesis sensitizes murine models of triple negative breast cancer to immunotherapy by activating B-cells and CD4+ T-cells Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Gs1-05  0.588
2019 Mose LE, Marron D, Parker JS. Abstract 1678: Accurate detection of expressed variation in RNA-seq Cancer Research. 79: 1678-1678. DOI: 10.1158/1538-7445.Sabcs18-1678  0.445
2019 Vincent B, Sambade M, Chai S, Siegel M, Cuaboy L, Holye A, Parker J, Perou C, Anders C. THER-06. GENOMIC AND IMMUNE CHARACTERIZATION OF TRIPLE NEGATIVE BREAST CANCER BRAIN METASTASES Neuro-Oncology Advances. 1: i11-i12. DOI: 10.1093/NOAJNL/VDZ014.049  0.549
2019 Fernandez-Martinez A, Tanioka M, Fan C, Parker JS, Hoadley KA, Krop I, Partridge A, Carey L, Perou CM. Predictive and prognostic value of B-cell gene-expression signatures and B-cell receptor (BCR) repertoire in HER2+ breast cancer : A correlative analysis of the CALGB 40601 clinical trial (Alliance) Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz240  0.734
2019 Prat A, Tsai Y-, Pascual T, Paré L, Vidal M, Adamo B, Brase JC, Johnston SRD, Ciruelos EM, Parker JS. PAM50MET: A prognostic model based on PAM50 and clinical variables in metastatic hormone receptor (HR)-positive/HER2 negative breast cancer. Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz095.006  0.45
2018 Bianchini G, Parker J, Carey L, Perou CM, Sica L, Prat A, Pieńkowski T, Im YH, Bianchi GV, Ling-Ming T, Liu MC, Lluch A, Semiglazov V, de la Haba-Rodriguez J, Oh DY, et al. Research-based PAM50 predicts risk of relapse in residual disease after anti-HER2 therapies. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: viii61. PMID 32137631 DOI: 10.1093/Annonc/Mdy270.187  0.432
2018 Zhao X, Little P, Hoyle AP, Pegna GJ, Hayward MC, Ivanova A, Parker JS, Marron DL, Soloway MG, Jo H, Salazar AH, Papakonstantinou MP, Bouchard DM, Jefferys SR, Hoadley KA, et al. The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma. Frontiers in Oncology. 8: 584. PMID 30662871 DOI: 10.3389/Fonc.2018.00584  0.602
2018 Kensler KH, Sankar VN, Wang J, Zhang X, Rubadue CA, Baker GM, Parker JS, Hoadley KA, Stancu AL, Pyle ME, Collins LC, Hunter DJ, Elissen AH, Hankinson SE, Tamimi RM, et al. PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30591591 DOI: 10.1158/1055-9965.Epi-18-0863  0.607
2018 Cai L, Tsai YH, Wang P, Wang J, Li D, Fan H, Zhao Y, Bareja R, Lu R, Wilson EM, Sboner A, Whang YE, Zheng D, Parker JS, Earp HS, et al. ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer. Molecular Cell. PMID 30270106 DOI: 10.1016/J.Molcel.2018.08.029  0.318
2018 Gucalp A, Traina TA, Eisner JR, Parker JS, Selitsky SR, Park BH, Elias AD, Baskin-Bey ES, Cardoso F. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Research and Treatment. PMID 30267249 DOI: 10.1007/S10549-018-4921-9  0.428
2018 Smith CC, Beckermann KE, Bortone DS, de Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. The Journal of Clinical Investigation. PMID 30137025 DOI: 10.1172/Jci121476  0.445
2018 Tanioka M, Fan C, Parker JS, Hoadley KA, Hu Z, Li Y, Hyslop TM, Pitcher BN, Soloway MG, Spears PA, Henry NL, Tolaney S, Dang CT, Krop I, Harris LN, et al. Integrated analysis of RNA and DNA from a phase III trial of trastuzumab-based neoadjuvant chemotherapy identifies response predictors in HER2-positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30037817 DOI: 10.1158/1078-0432.Ccr-17-3431  0.703
2018 Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, Liu XD, Jonasch E, Xie L, Chen X, Yao X, Teh BT, Tan P, Zheng X, Li M, ... ... Parker JS, et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science (New York, N.Y.). 361: 290-295. PMID 30026228 DOI: 10.1126/Science.Aap8411  0.488
2018 Desai NV, Torous V, Parker J, Auman JT, Rosson GB, Cruz C, Perou CM, Schnitt SJ, Tung N. Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay. Breast Cancer Research : Bcr. 20: 75. PMID 29996866 DOI: 10.1186/S13058-018-1005-Z  0.57
2018 Gorlov I, Orlow I, Ringelberg C, Hernando E, Ernstoff MS, Cheng C, Her S, Parker JS, Thompson CL, Gerstenblith MR, Berwick M, Amos C. Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Research. PMID 29975213 DOI: 10.1097/Cmr.0000000000000473  0.404
2018 Van Swearingen AED, Siegel MB, Deal AM, Sambade MJ, Hoyle A, Hayes DN, Jo H, Little P, Dees EC, Muss H, Jolly T, Zagar TM, Patel N, Miller CR, Parker JS, et al. LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases. Breast Cancer Research and Treatment. PMID 29938395 DOI: 10.1007/S10549-018-4852-5  0.412
2018 Bensen JT, Graff M, Young KL, Sethupathy P, Parker J, Pecot CV, Currin K, Haddad SA, Ruiz-Narváez EA, Haiman CA, Hong CC, Sucheston-Campbell LE, Zhu Q, Liu S, Yao S, et al. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women. Breast Cancer Research : Bcr. 20: 45. PMID 29871690 DOI: 10.1186/S13058-018-0964-4  0.35
2018 Coombs CC, Gillis NK, Tan X, Berg JS, Ball MC, Balasis ME, Montgomery ND, Bolton K, Parker JS, Mesa TE, Yoder SJ, Hayward MC, Patel NM, Richards KL, Walko CM, et al. Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29866652 DOI: 10.1158/1078-0432.Ccr-18-1201  0.326
2018 Chiang YC, Park IY, Terzo EA, Tripathi DN, Mason FM, Fahey CC, Karki M, Shuster CB, Sohn BH, Chowdhury P, Powell RT, Ohi R, Tsai YH, de Cubas AA, Khan A, ... ... Parker JS, et al. SETD2 Haploinsufficiency for Microtubule Methylation is an Early Driver of Genomic Instability in Renal Cell Carcinoma. Cancer Research. PMID 29724720 DOI: 10.1158/0008-5472.Can-17-3460  0.307
2018 Tsai YH, Parker JS, Yang IV, Kelada SNP. Meta-Analysis of Airway Epithelia Gene Expression in Asthma. The European Respiratory Journal. PMID 29650561 DOI: 10.1183/13993003.01962-2017  0.311
2018 Dellon ES, Selitsky SR, Genta RM, Lash RH, Parker JS. Gene expression-phenotype associations in adults with eosinophilic esophagitis. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 29628359 DOI: 10.1016/J.Dld.2018.03.021  0.324
2018 Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Parker JS, et al. The Immune Landscape of Cancer. Immunity. PMID 29628290 DOI: 10.1016/J.Immuni.2018.03.023  0.424
2018 Siegel MB, He X, Hoadley KA, Hoyle A, Pearce JB, Garrett AL, Kumar S, Moylan VJ, Brady CM, Van Swearingen AE, Marron D, Gupta GP, Thorne LB, Kieran N, Livasy C, ... ... Parker JS, et al. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. The Journal of Clinical Investigation. PMID 29480819 DOI: 10.1172/Jci96153  0.733
2018 Montgomery ND, Selitsky SR, Patel NM, Hayes DN, Parker JS, Weck KE. Identification of Germline Variants in Tumor Genomic Sequencing Analysis. The Journal of Molecular Diagnostics : Jmd. 20: 123-125. PMID 29249243 DOI: 10.1016/J.Jmoldx.2017.09.008  0.343
2018 Coombs CC, Gillis N, Bolton KL, Berg JS, Tan X, Hayward MC, Patel NM, Ball M, Balasis M, Mesa T, Montgomery N, Richards KL, Kim WY, Hayes DN, Earp S, ... Parker JS, et al. Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired commercial next-generation sequencing assays. Journal of Clinical Oncology. 36: 12068-12068. DOI: 10.1200/Jco.2018.36.15_Suppl.12068  0.327
2018 Zeidner JF, Vincent BG, Ivanova A, Foster MC, Coombs CC, Jamieson K, Van Deventer HW, Blanchard L, Frank C, Gallagher S, Matson M, Pepin K, Vaught L, Vogler N, Miller K, ... ... Parker JS, et al. Genomics Reveal Potential Biomarkers of Response to Pembrolizumab after High Dose Cytarabine in an Ongoing Phase II Trial in Relapsed/Refractory AML Blood. 132: 4054-4054. DOI: 10.1182/Blood-2018-99-116608  0.321
2018 Dixon J, Turnbull A, Tanioka M, Wheless A, Garrett A, Martinez-Perez C, Parker J, He X, Sims A, Thomas J, Carey L, Perou C. Abstract P4-03-01: Causes of endocrine therapy resistance: An in-depth genomic analysis of resistant multidrug ER+ breast cancers Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-03-01  0.364
2018 Vincent BG, Sambade M, Chai S, Siegel MB, Cuaboy L, Hoyle A, Parker J, Perou CM, Anders CK. Abstract 4055: Genomic and immune characterization of triple-negative breast cancer brain metastases Cancer Research. 78: 4055-4055. DOI: 10.1158/1538-7445.Am2018-4055  0.599
2018 Bowers LW, McDonell SB, Rossi E, Montgomery S, Parker J, Hursting SD. Abstract 2233: Breaking the obesity-cancer link: Nutritional modulation of inflammation and epigenetic reprogramming Cancer Research. 78: 2233-2233. DOI: 10.1158/1538-7445.Am2018-2233  0.343
2018 Tanioka M, Parker JS, Henry LN, Tolaney S, Dang C, Krop IE, Harris L, Hillman D, Polley M, Berry DA, Winer EP, Carey LA, Perou CM. A prognostic model integrating clinical data and gene signatures in phase III neoadjuvant trial CALGB 40601 (Alliance) Annals of Oncology. 29: vii50. DOI: 10.1093/Annonc/Mdy373  0.468
2018 Dellon ES, Bodwin K, He M, Parker JS, Nobel AB, Selitsky SR. 461 - Pre-Tretment Differential Correlaton of Gene Expression, Rather than Differential Expression, is Associated with Subsequent Response to Topcial Steroid Treatment in Eosinophilic Esophagitis Gastroenterology. 154: S-107. DOI: 10.1016/S0016-5085(18)30795-9  0.311
2018 Gupta G, Kumar S, Marron D, Amdur R, Hayes D, Weiss J, Grilley-Olson J, Zanation A, Hackman T, Zevallos J, Patel S, Weissler M, Parker J, Mendenhall W, Chera B. Circulating Tumor HPV16 DNA as a Biomarker of Tumor Genomics and Disease Control in HPV-associated Oropharyngeal Squamous Cell Carcinoma International Journal of Radiation Oncology*Biology*Physics. 100: 1310-1311. DOI: 10.1016/J.Ijrobp.2017.12.291  0.301
2017 Patel NM, Michelini VV, Snell JM, Balu S, Hoyle AP, Parker JS, Hayward MC, Eberhard DA, Salazar AH, McNeillie P, Xu J, Huettner CS, Koyama T, Utro F, Rhrissorrakrai K, et al. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing. The Oncologist. PMID 29158372 DOI: 10.1634/Theoncologist.2017-0170  0.358
2017 Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS, Patel N, Mlombe YB, Mulima G, Liomba NG, Wolf LL, Shores CG, Gopal S, Sharpless NE. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. Jci Insight. 2. PMID 29148985 DOI: 10.1172/jci.insight.98457  0.459
2017 Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, et al. Combating subclonal evolution of resistant cancer phenotypes. Nature Communications. 8: 1231. PMID 29093439 DOI: 10.1038/S41467-017-01174-3  0.441
2017 Taylor NA, Vick SC, Iglesia MD, Brickey WJ, Midkiff BR, McKinnon KP, Reisdorf S, Anders CK, Carey LA, Parker JS, Perou CM, Vincent BG, Serody JS. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer. The Journal of Clinical Investigation. PMID 28825599 DOI: 10.1172/Jci90499  0.592
2017 O'Flanagan CH, Rossi EL, McDonell SB, Chen X, Tsai YH, Parker JS, Usary J, Perou CM, Hursting SD. Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer. Npj Breast Cancer. 3: 26. PMID 28748213 DOI: 10.1038/s41523-017-0027-5  0.527
2017 Bailey ST, Smith AM, Kardos J, Wobker SE, Wilson HL, Krishnan B, Saito R, Lee HJ, Zhang J, Eaton SC, Williams LA, Manocha U, Peters DJ, Pan X, Carroll TJ, ... ... Parker JS, et al. MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma. Nature Communications. 8: 15770. PMID 28593993 DOI: 10.1038/Ncomms15770  0.314
2017 Chang J, Tan W, Ling Z, Xi R, Shao M, Chen M, Luo Y, Zhao Y, Liu Y, Huang X, Xia Y, Hu J, Parker JS, Marron D, Cui Q, et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nature Communications. 8: 15290. PMID 28548104 DOI: 10.1038/Ncomms15290  0.359
2017 Prat A, Navarro A, Paré L, Reguart N, Galvan P, Pascual T, Martínez A, Nuciforo P, Comerma L, Alos L, Pardo N, Cedrés S, Fan C, Parker JS, Gaba L, et al. Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma and melanoma. Cancer Research. PMID 28487385 DOI: 10.1158/0008-5472.Can-16-3556  0.328
2017 Van Swearingen AED, Sambade MJ, Siegel MB, Sud S, McNeill RS, Bevill SM, Chen X, Bash RE, Mounsey L, Golitz BT, Santos C, Deal A, Parker JS, Rashid N, Miller CR, et al. Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer. Neuro-Oncology. PMID 28486691 DOI: 10.1093/Neuonc/Nox052  0.384
2017 Silva GO, Siegel MB, Mose LE, Parker JS, Sun W, Perou CM, Chen M. SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling. Genome Biology. 18: 66. PMID 28390427 DOI: 10.1186/S13059-017-1193-3  0.491
2017 Mehta GA, Parker JS, Silva GO, Hoadley KA, Perou CM, Gatza ML. Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer. Breast Cancer Research and Treatment. PMID 28176176 DOI: 10.1007/S10549-017-4139-2  0.723
2017 Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. Science Translational Medicine. 9. PMID 28148846 DOI: 10.1126/Scitranslmed.Aah6510  0.347
2017 Zawistowski JS, Bevill SM, Goulet DR, Stuhlmiller TJ, Beltran AS, Olivares-Quintero JF, Singh D, Sciaky N, Parker JS, Rashid NU, Chen X, Duncan JS, Whittle MC, Angus SP, Velarde SH, et al. Enhancer Remodeling During Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacological Targeting of the P-TEFb Complex. Cancer Discovery. PMID 28108460 DOI: 10.1158/2159-8290.Cd-16-0653  0.524
2017 Hoadley KA, Siegel MB, Kanchi KL, Miller CA, Ding L, Zhao W, He X, Parker JS, Wendl MC, Fulton RS, Demeter RT, Wilson RK, Carey LA, Perou CM, Mardis ER. Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases. Plos Medicine. 14: e1002222. PMID 28068332 DOI: 10.1371/journal.pmed.1002222  0.684
2017 Nishijima TF, Kardos J, Chai S, Smith CC, Bortone DS, Mose LE, Selitsky SR, Sanoff HK, Parker JS, Lee MS, Vincent BG. Molecular and clinical characterization of a claudin (CLDN)-low subtype of gastric cancer (GC). Journal of Clinical Oncology. 35: 67-67. DOI: 10.1200/Jco.2017.35.4_Suppl.67  0.487
2017 Lee MS, Selitsky SR, Parker JS. Prognostic impact of cytomegalovirus (CMV) detection in colorectal cancer (CRC). Journal of Clinical Oncology. 35: e15120-e15120. DOI: 10.1200/Jco.2017.35.15_Suppl.E15120  0.379
2017 Swearingen AEDV, Sambade MJ, Siegel MB, Sud S, Bevill SM, Golitz BT, Bash RE, Santos CM, Darr DB, Parker JS, Miller CR, Johnson GL, Anders CK. Abstract A03: Several rational combination kinase inhibitor treatments identified by synthetic lethality screens are efficacious in intracranial triple negative breast cancer models Molecular Cancer Therapeutics. 16. DOI: 10.1158/1538-8514.Synthleth-A03  0.399
2017 Vick SC, Taylor NA, Iglesia MD, Brickey WJ, Carey LA, Midkiff BR, McKinnon KP, Reisdorf S, Parker JS, Perou CM, Vincent BG, Serody JS. Abstract 568: Regulatory T cell recruitment limits the effectiveness of checkpoint inhibition for claudin-low breast cancer Immunology. 77: 568-568. DOI: 10.1158/1538-7445.Am2017-568  0.564
2017 Mose LE, Hayes DN, Perou CM, Parker JS. Abstract 3592: Improved indel detection in RNA-seq data via assembly based re-alignment reveals expressed Epidermal Growth Factor Receptor indels in Lung Adenocarcinoma Cancer Research. 77: 3592-3592. DOI: 10.1158/1538-7445.Am2017-3592  0.452
2017 Little P, Hayes DN, Parker J, Zevallos J. Abstract 3584: Statistical considerations in tumor only variant calling Cancer Research. 77: 3584-3584. DOI: 10.1158/1538-7445.Am2017-3584  0.372
2017 Recio SG, Fan C, Siegel M, Parker JS, Duronio GN, Prat A, Perou CM. Abstract 3119: Identification of genetic drivers in HER2enriched/HER2negative breast cancer Cancer Research. 77: 3119-3119. DOI: 10.1158/1538-7445.Am2017-3119  0.662
2017 Picornell A, Echavarria Diaz-Guardamino I, Alvarez Castillo E, Lopez-Tarruella Cobo S, Jerez Y, Hoadley K, Parker J, del Monte-Millán M, Ramos Medina R, Gayarre J, Ocaña I, Cebollero M, Massarrah T, Moreno Antón F, García-Saenz J, et al. Breast cancer PAM50 subtypes: Correlation between RNA-Seq and multiplexed gene expression platforms Annals of Oncology. 28: v56-v57. DOI: 10.1093/Annonc/Mdx362.036  0.714
2016 Snowden E, Porter W, Hahn F, Ferguson M, Tong F, Parker JS, Middlebrook A, Ghanekar S, Dillmore WS, Blaesius R. Immunophenotyping and Transcriptomic Outcomes in PDX-derived TNBC Tissue. Molecular Cancer Research : McR. PMID 28039356 DOI: 10.1158/1541-7786.Mcr-16-0286-T  0.436
2016 Hoadley KA, Siegel MB, Kanchi KL, Miller CA, Ding L, Zhao W, He X, Parker JS, Wendl MC, Fulton RS, Demeter RT, Wilson RK, Carey LA, Perou CM, Mardis ER. Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases. Plos Medicine. 13: e1002174. PMID 27923045 DOI: 10.1371/Journal.Pmed.1002174  0.7
2016 Prat A, Lluch A, Turnbull AK, Dunbier AK, Calvo L, Albanell J, de la Haba-Rodríguez J, Arcusa A, Chacón I, Sánchez-Rovira P, Plazaola A, Muñoz M, Paré L, Parker JS, Ribelles N, et al. A PAM50-based Chemo-Endocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27903675 DOI: 10.1158/1078-0432.Ccr-16-2092  0.589
2016 Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS, Patel N, Mlombe YB, Mulima G, Liomba NG, Wolf LL, Shores CG, Gopal S, Sharpless NE. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. Jci Insight. 1: e88755. PMID 27734031 DOI: 10.1172/Jci.Insight.88755  0.601
2016 Kardos J, Chai S, Mose LE, Selitsky SR, Krishnan B, Saito R, Iglesia MD, Milowsky MI, Parker JS, Kim WY, Vincent BG. Claudin-low bladder tumors are immune infiltrated and actively immune suppressed. Jci Insight. 1: e85902. PMID 27699256 DOI: 10.1172/Jci.Insight.85902  0.458
2016 Mose LE, Selitsky SR, Bixby LM, Marron DL, Iglesia MD, Serody JS, Perou CM, Vincent BG, Parker JS. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer. Bioinformatics (Oxford, England). PMID 27559159 DOI: 10.1093/Bioinformatics/Btw526  0.474
2016 Hu S, Parker J, Divaris K, Padilla R, Murrah V, Wright JT. Ameloblastoma Phenotypes Reflected in Distinct Transcriptome Profiles. Scientific Reports. 6: 30867. PMID 27491308 DOI: 10.1038/Srep30867  0.332
2016 Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types. Journal of the National Cancer Institute. 108. PMID 27335052 DOI: 10.1093/Jnci/Djw144  0.65
2016 Souroullas GP, Jeck WR, Parker JS, Simon JM, Liu JY, Paulk J, Xiong J, Clark KS, Fedoriw Y, Qi J, Burd CE, Bradner JE, Sharpless NE. An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nature Medicine. PMID 27135738 DOI: 10.1038/Nm.4092  0.34
2016 Seifert BA, O'Daniel JM, Amin K, Marchuk DS, Patel NM, Parker JS, Hoyle AP, Mose LE, Marron A, Hayward MC, Bizon C, Wilhelmsen KC, Evans JP, Earp HS, Sharpless N, et al. Germline Analysis from Tumor-Germline Sequencing Dyads to identify clinically actionable secondary findings. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27083775 DOI: 10.1158/1078-0432.Ccr-16-0015  0.453
2016 Hu S, Divaris K, Parker J, Padilla R, Murrah V, Wright JT. Transcriptome Variability in Keratocystic Odontogenic Tumor Suggests Distinct Molecular Subtypes. Scientific Reports. 6: 24236. PMID 27066764 DOI: 10.1038/Srep24236  0.387
2016 Billard MJ, Fitzhugh DJ, Parker JS, Brozowski JM, McGinnis MW, Timoshchenko RG, Serafin DS, Lininger R, Klauber-Demore N, Sahagian G, Truong YK, Sassano MF, Serody JS, Tarrant TK. G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis. Plos One. 11: e0152856. PMID 27049755 DOI: 10.1371/Journal.Pone.0152856  0.505
2016 López-Knowles E, Gao Q, Cheang MC, Morden J, Parker J, Martin LA, Pinhel I, McNeill F, Hills M, Detre S, Afentakis M, Zabaglo L, Dodson A, Skene A, Holcombe C, et al. Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas. Breast Cancer Research : Bcr. 18: 39. PMID 27036195 DOI: 10.1186/S13058-016-0696-2  0.456
2016 Zhao W, Hoadley KA, Parker JS, Perou CM. Identification of mRNA isoform switching in breast cancer. Bmc Genomics. 17: 181. PMID 26939613 DOI: 10.1186/S12864-016-2521-9  0.719
2016 Brooks SA, Khandani A, Fielding J, Lin W, Sills T, Lee Y, Arreola A, Milowsky MI, Wallen EM, Woods ME, Smith AB, Nielsen ME, Parker JS, Lalush DS, Rathmell WK. Alternate metabolic programs define regional variation of relevant biological features in renal cell carcinoma progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26787754 DOI: 10.1158/1078-0432.Ccr-15-2115  0.358
2016 Grilley-Olsen J, Keith K, Hayward M, Dees E, Deal A, Ivanova A, Benbow J, Parker J, Patel N, Eberhard D, Mieczkowski P, Weck K, Hayes D, Muss H, Jolly T, et al. Abstract PD6-07: Genomic sequencing in metastatic breast cancer patients to inform clinical practice at the University of North Carolina at Chapel Hill Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Pd6-07  0.445
2016 Olayiwola O, Ogundiran T, Hardeman A, Yoshimatsu T, Clayton W, Adeoye A, Ademola A, Ajani M, Khramtsova G, Grushko T, Huo D, Zheng Y, Parker J, Perou C, Olopade O. Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-04-05  0.517
2016 Miller K, Krop I, Schwartzberg L, Abramson V, Garcia-Estevez L, Eakle J, Nanda R, Yardley D, Ademuyiwa F, Chan S, Crown J, Danso M, Gelmon K, Ma L, Martinez-Janez N, ... ... Parker J, et al. Abstract P3-07-25: Improved clinical outcomes on enzalutamide observed in patients with PREDICT AR+ triple-negative breast cancer: prognosis or prediction? Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-07-25  0.359
2016 Phan V, Protter A, Peterson A, Parker J, Yoon K, Tudor I, Paton V, Noonberg S, Uppal H. Abstract P2-07-04: A novel diagnostic androgen receptor gene signature links clinical outcomes and preclinical response to enzalutamide, paclitaxel or the combination in triple-negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-07-04  0.454
2016 Vincent BG, Kim W, Kardos J, Chai S, Parker J, Mose L, Selitsky S, Iglesia M, Milowsky M. Abstract 5120: The novel claudin-low molecular subtype of high-grade urothelial bladder cancer is highly immunogenic yet immunosuppressed Cancer Research. 76: 5120-5120. DOI: 10.1158/1538-7445.Am2016-5120  0.511
2016 Lee W, Jo H, Yin X, Eberhard DA, Patel NM, Hayward MC, Salazar AH, Parker JS, Kim WY, Earp HS, Sharpless NE, Hayes DN. Abstract 4499: Integration of targeted RNA sequencing to targeted DNA sequencing for the characterization of clinically relevant variants in a population of thousands of patients treated on clinical trial Cancer Research. 76: 4499-4499. DOI: 10.1158/1538-7445.Am2016-4499  0.401
2016 Porter W, Hahn F, Snowden E, Ferguson M, Tong F, Dillmore S, Parker JS, Middlebrook A, Ghanekar S, Blaesius R. Abstract 2391: Flow cytometric sorting of subpopulations followed by RNASeq reveals distinct phenotypes in PDX model of basal breast cancer Cancer Research. 76: 2391-2391. DOI: 10.1158/1538-7445.Am2016-2391  0.476
2015 Gendoo DM, Ratanasirigulchai N, Schröder MS, Paré L, Parker JS, Prat A, Haibe-Kains B. Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinformatics (Oxford, England). PMID 26607490 DOI: 10.1093/Bioinformatics/Btv693  0.477
2015 Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, ... ... Parker JS, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The New England Journal of Medicine. PMID 26536169 DOI: 10.1056/Nejmoa1505917  0.616
2015 Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, ... ... Parker JS, et al. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. Bmc Medical Genomics. 8: 54. PMID 26297356 DOI: 10.1186/S12920-015-0129-6  0.615
2015 Parker JS, Perou CM. Tumor Heterogeneity: Focus on the Leaves, the Trees, or the Forest? Cancer Cell. 28: 149-50. PMID 26267531 DOI: 10.1016/J.Ccell.2015.07.011  0.551
2015 Silva GO, He X, Parker JS, Gatza ML, Carey LA, Hou JP, Moulder SL, Marcom PK, Ma J, Rosen JM, Perou CM. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer. Breast Cancer Research and Treatment. PMID 26109346 DOI: 10.1007/S10549-015-3476-2  0.64
2015 Zhao X, Wang A, Walter V, Patel NM, Eberhard DA, Hayward MC, Salazar AH, Jo H, Soloway MG, Wilkerson MD, Parker JS, Yin X, Zhang G, Siegel MB, Rosson GB, et al. Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC. Plos One. 10: e0129280. PMID 26076459 DOI: 10.1371/Journal.Pone.0129280  0.406
2015 Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, ... ... Parker JS, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121  0.61
2015 Cheang MC, Martin M, Nielsen TO, Prat A, Voduc D, Rodriguez-Lescure A, Ruiz A, Chia S, Shepherd L, Ruiz-Borrego M, Calvo L, Alba E, Carrasco E, Caballero R, Tu D, ... ... Parker J, et al. Defining breast cancer intrinsic subtypes by quantitative receptor expression. The Oncologist. 20: 474-82. PMID 25908555 DOI: 10.1634/Theoncologist.2014-0372  0.595
2015 Stuhlmiller TJ, Miller SM, Zawistowski JS, Nakamura K, Beltran AS, Duncan JS, Angus SP, Collins KA, Granger DA, Reuther RA, Graves LM, Gomez SM, Kuan PF, Parker JS, Chen X, et al. Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains. Cell Reports. 11: 390-404. PMID 25865888 DOI: 10.1016/J.Celrep.2015.03.037  0.308
2015 Hu S, Parker J, Wright JT. Towards unraveling the human tooth transcriptome: the dentome. Plos One. 10: e0124801. PMID 25849153 DOI: 10.1371/Journal.Pone.0124801  0.348
2015 Karginova O, Siegel MB, Van Swearingen AE, Deal AM, Adamo B, Sambade MJ, Bazyar S, Nikolaishvili-Feinberg N, Bash R, O'Neal S, Sandison K, Parker JS, Santos C, Darr D, Zamboni W, et al. Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 14: 920-30. PMID 25824335 DOI: 10.1158/1535-7163.Mct-14-0474  0.454
2015 Ferguson J, McKibben M, Parker JS, Wallen E, Wood CG, Powles T, Rathmell K. Evaluation of the effects of neoadjuvant pazopanib for renal cell carcinoma on intratumor genetic heterogeneity. Journal of Clinical Oncology. 33: 425-425. DOI: 10.1200/Jco.2015.33.7_Suppl.425  0.354
2015 Parker JS, Peterson AC, Tudor IC, Hoffman J, Uppal H. A novel biomarker to predict sensitivity to enzalutamide (ENZA) in TNBC. Journal of Clinical Oncology. 33: 1083-1083. DOI: 10.1200/Jco.2015.33.15_Suppl.1083  0.317
2015 Hoadley KA, Barry WT, Pitcher BN, Parker JS, Wilkerson MD, Irvin W, Henry NL, Tolaney SM, Dang C, Krop IE, Berry DA, Mardis ER, Perou CM, Winer EP, Hudis CA, et al. Abstract S3-06: Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S3-06  0.712
2015 Dixon JM, Turnbull AK, Fan C, Parker JS, He X, Arthur L, Martinez-Perez C, Renshaw L, Perou C. Abstract S1-05: In-depth genomic analysis of ER+ breast cancers during development of endocrine resistance Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-S1-05  0.619
2015 Hayes DN, Grilley-Olson JE, Eberhard DA, Patel NM, Parker JS, Weck KE, Kim WY, Hayward MC, Earp HS, Sharpless NE. Abstract CT133: The impact of gene panel sequencing on clinical care in patients with cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct133  0.416
2015 Swearingen AEDV, Siegel MB, Sambade MJ, Sud S, Miller SM, Silva G, Bash RE, Santos CM, Darr DB, Golitz B, Parker JS, Miller CR, Johnson GL, Anders CK. Abstract 2579: Combination therapy with MEK inhibition is efficacious in intracranial triple negative breast cancer models Cancer Research. 75: 2579-2579. DOI: 10.1158/1538-7445.Am2015-2579  0.468
2014 Seiser E, Gillis N, Parker J, Hayes DN, Eberhard D, Richards K, Auman JT, Innocenti F. 1614PPHARMACOGENETIC EVALUATION OF TARGETED DNA SEQUENCING IN CANCER PATIENTS. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv558-iv559. PMID 28172051 DOI: 10.1093/Annonc/Mdu358.45  0.516
2014 Gatza ML, Silva GO, Parker JS, Fan C, Perou CM. An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer. Nature Genetics. 46: 1051-9. PMID 25151356 DOI: 10.1038/Ng.3073  0.606
2014 Prat A, Carey LA, Adamo B, Vidal M, Tabernero J, Cortés J, Parker JS, Perou CM, Baselga J. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer. Journal of the National Cancer Institute. 106. PMID 25139534 DOI: 10.1093/Jnci/Dju152  0.648
2014 Orvis T, Hepperla A, Walter V, Song S, Simon J, Parker J, Wilkerson MD, Desai N, Major MB, Hayes DN, Davis IJ, Weissman B. BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization. Cancer Research. 74: 6486-98. PMID 25115300 DOI: 10.1158/0008-5472.Can-14-0061  0.372
2014 Prat A, Lluch A, Albanell J, Barry WT, Fan C, Chacón JI, Parker JS, Calvo L, Plazaola A, Arcusa A, Seguí-Palmer MA, Burgues O, Ribelles N, Rodriguez-Lescure A, Guerrero A, et al. Predicting response and survival in chemotherapy-treated triple-negative breast cancer. British Journal of Cancer. 111: 1532-41. PMID 25101563 DOI: 10.1038/Bjc.2014.444  0.583
2014 Rathmell WK, Brooks SA, Parker JS, Nielsen ME. Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's letter to the editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84. European Urology. 66: e92. PMID 25037640 DOI: 10.1016/J.Eururo.2014.07.002  0.334
2014 Anders C, Deal AM, Abramson V, Liu MC, Storniolo AM, Carpenter JT, Puhalla S, Nanda R, Melhem-Bertrandt A, Lin NU, Kelly Marcom P, Van Poznak C, Stearns V, Melisko M, Smith JK, ... ... Parker J, et al. TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases. Breast Cancer Research and Treatment. 146: 557-66. PMID 25001612 DOI: 10.1007/S10549-014-3039-Y  0.597
2014 Wilkerson MD, Cabanski CR, Sun W, Hoadley KA, Walter V, Mose LE, Troester MA, Hammerman PS, Parker JS, Perou CM, Hayes DN. Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Nucleic Acids Research. 42: e107. PMID 24970867 DOI: 10.1093/Nar/Gku489  0.661
2014 Iglesia MD, Vincent BG, Parker JS, Hoadley KA, Carey LA, Perou CM, Serody JS. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3818-29. PMID 24916698 DOI: 10.1158/1078-0432.Ccr-13-3368  0.723
2014 Mose LE, Wilkerson MD, Hayes DN, Perou CM, Parker JS. ABRA: improved coding indel detection via assembly-based realignment. Bioinformatics (Oxford, England). 30: 2813-5. PMID 24907369 DOI: 10.1093/Bioinformatics/Btu376  0.41
2014 Zhao W, He X, Hoadley KA, Parker JS, Hayes DN, Perou CM. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. Bmc Genomics. 15: 419. PMID 24888378 DOI: 10.1186/1471-2164-15-419  0.621
2014 Jeck WR, Parker J, Carson CC, Shields JM, Sambade MJ, Peters EC, Burd CE, Thomas NE, Chiang DY, Liu W, Eberhard DA, Ollila D, Grilley-Olson J, Moschos S, Neil Hayes D, et al. Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. Pigment Cell & Melanoma Research. 27: 653-63. PMID 24628946 DOI: 10.1111/Pcmr.12238  0.398
2014 Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. European Urology. 66: 77-84. PMID 24613583 DOI: 10.1016/J.Eururo.2014.02.035  0.399
2014 Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, Yeh JJ, Milowsky MI, Iyer G, Parker JS, Kim WY. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proceedings of the National Academy of Sciences of the United States of America. 111: 3110-5. PMID 24520177 DOI: 10.1073/Pnas.1318376111  0.672
2014 Simon JM, Hacker KE, Singh D, Brannon AR, Parker JS, Weiser M, Ho TH, Kuan PF, Jonasch E, Furey TS, Prins JF, Lieb JD, Rathmell WK, Davis IJ. Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects. Genome Research. 24: 241-50. PMID 24158655 DOI: 10.1101/Gr.158253.113  0.375
2014 Giannikopoulos P, St. John JA, Parker JS, Westesson O, Hahner NJ, Karachaliou N, Costa C, Caulin AF, Lozano MD, Perez-Gracia JL, Curioni Fontecedro A, Jantus-Lewintre E, Vergnenegre A, Gervais R, Bordoni R, et al. Integrated genomic analysis for revealing broad remodeling of EGFR-targeted therapy resistant lung cancers. Journal of Clinical Oncology. 32: 8083-8083. DOI: 10.1200/Jco.2014.32.15_Suppl.8083  0.317
2014 Giannikopoulos P, John JS, Hahner N, Parker JS, Karachaliou N, Costa C, Westesson O, Parikh U, Foo CK, Cauhlin AF, Lozano MD, Viteri S, Perez-Gracia JL, Curioni A, Jantus-Lewintre E, et al. Abstract 954: Integrated genomic analysis by whole exome and transcriptome sequencing of tumor samples from EGFR-mutant non-small-cell lung cancer patients with acquired resistance to erlotinib Cancer Research. 74: 954-954. DOI: 10.1158/1538-7445.Am2014-954  0.374
2014 Jo H, Patel NM, Weck KE, Eberhard DA, Hayes DN, Parker JS, Hayward M, Salazar A, Grilley-Olson JE. Abstract 5598: Correlating molecular and histopathologic tumor purity: An analysis of 816 patients Cancer Research. 74: 5598-5598. DOI: 10.1158/1538-7445.Am2014-5598  0.399
2014 Swearingen AEDV, Siegel MB, Bash R, Golitz B, Santos C, Darr D, Parker J, Johnson GL, Miller CR, Anders CK. Abstract 5449A: PI3K and MEK inhibition in intracranial triple negative breast cancer: Efficacy of BKM120 and AZD6244 in preclinical mouse models Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-5449A  0.459
2013 Bardowell SA, Parker J, Fan C, Crandell J, Perou CM, Swift-Scanlan T. Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns. Breast Cancer Research and Treatment. 142: 365-80. PMID 24212716 DOI: 10.1007/S10549-013-2738-0  0.602
2013 Prat A, Karginova O, Parker JS, Fan C, He X, Bixby L, Harrell JC, Roman E, Adamo B, Troester M, Perou CM. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Research and Treatment. 142: 237-55. PMID 24162158 DOI: 10.1158/1538-7445.Am2011-3328  0.586
2013 Roll JD, Rivenbark AG, Sandhu R, Parker JS, Jones WD, Carey LA, Livasy CA, Coleman WB. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation. Experimental and Molecular Pathology. 95: 276-87. PMID 24045095 DOI: 10.1016/J.Yexmp.2013.09.001  0.517
2013 Polkinghorn WR, Parker JS, Lee MX, Kass EM, Spratt DE, Iaquinta PJ, Arora VK, Yen WF, Cai L, Zheng D, Carver BS, Chen Y, Watson PA, Shah NP, Fujisawa S, et al. Androgen receptor signaling regulates DNA repair in prostate cancers. Cancer Discovery. 3: 1245-53. PMID 24027196 DOI: 10.1158/2159-8290.Cd-13-0172  0.327
2013 King IF, Yandava CN, Mabb AM, Hsiao JS, Huang HS, Pearson BL, Calabrese JM, Starmer J, Parker JS, Magnuson T, Chamberlain SJ, Philpot BD, Zylka MJ. Topoisomerases facilitate transcription of long genes linked to autism. Nature. 501: 58-62. PMID 23995680 DOI: 10.1038/Nature12504  0.324
2013 Cabanski CR, Wilkerson MD, Soloway M, Parker JS, Liu J, Prins JF, Marron JS, Perou CM, Hayes DN. BlackOPs: increasing confidence in variant detection through mappability filtering. Nucleic Acids Research. 41: e178. PMID 23935067 DOI: 10.1093/Nar/Gkt692  0.469
2013 Cleary SP, Jeck WR, Zhao X, Chen K, Selitsky SR, Savich GL, Tan TX, Wu MC, Getz G, Lawrence MS, Parker JS, Li J, Powers S, Kim H, Fischer S, et al. Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology (Baltimore, Md.). 58: 1693-702. PMID 23728943 DOI: 10.1002/Hep.26540  0.316
2013 Zawistowski JS, Nakamura K, Parker JS, Granger DA, Golitz BT, Johnson GL. MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition. Molecular and Cellular Biology. 33: 2260-74. PMID 23530058 DOI: 10.1128/Mcb.00269-13  0.354
2013 Prat A, Cheang MC, Martín M, Parker JS, Carrasco E, Caballero R, Tyldesley S, Gelmon K, Bernard PS, Nielsen TO, Perou CM. Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 203-9. PMID 23233704 DOI: 10.1200/Jco.2012.43.4134  0.642
2013 Rathmell K, Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Nielsen ME. A validated 34-gene signature for assessing risk of recurrence in clear cell renal cell carcinoma. Journal of Clinical Oncology. 31: 4522-4522. DOI: 10.1200/Jco.2013.31.15_Suppl.4522  0.306
2013 Hoadley KA, Fan C, Wilkerson MD, Mose LE, Jefferys SR, Auman JT, Parker JS, Hayes DN, Perou CM. Abstract SY12-03: Multi-tumor analysis of TCGA data identifies expression commonalities across tumor types. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Sy12-03  0.695
2013 Cleary SP, Jeck WR, Zhao X, Selitsky SR, Savich GL, Tan T, Wu MC, Getz G, Lawrence MS, Parker JS, Li J, Powers S, Kim H, Fischer SE, Guindi M, et al. Abstract 4598: Identification of driver genes in hepatocellular carcinoma by exome sequencing. Cancer Research. 73: 4598-4598. DOI: 10.1158/1538-7445.Am2013-4598  0.356
2012 Chao HH, He X, Parker JS, Zhao W, Perou CM. Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer. Plos One. 7: e51719. PMID 23284754 DOI: 10.1371/Journal.Pone.0051719  0.735
2012 Cabanski CR, Cavin K, Bizon C, Wilkerson MD, Parker JS, Wilhelmsen KC, Perou CM, Marron JS, Hayes DN. ReQON: a Bioconductor package for recalibrating quality scores from next-generation sequencing data. Bmc Bioinformatics. 13: 221. PMID 22946927 DOI: 10.1186/1471-2105-13-221  0.426
2012 Prat A, Parker JS, Fan C, Perou CM. PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer. Breast Cancer Research and Treatment. 135: 301-6. PMID 22752290 DOI: 10.1007/S10549-012-2143-0  0.617
2012 Chia SK, Bramwell VH, Tu D, Shepherd LE, Jiang S, Vickery T, Mardis E, Leung S, Ung K, Pritchard KI, Parker JS, Bernard PS, Perou CM, Ellis MJ, Nielsen TO. A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4465-72. PMID 22711706 DOI: 10.1158/1078-0432.Ccr-12-0286  0.591
2012 Prat A, Parker JS, Fan C, Cheang MC, Miller LD, Bergh J, Chia SK, Bernard PS, Nielsen TO, Ellis MJ, Carey LA, Perou CM. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2866-73. PMID 22532584 DOI: 10.1200/Jco.2011.29.15_Suppl.502  0.615
2012 Dahlman KB, Parker JS, Shamu T, Hieronymus H, Chapinski C, Carver B, Chang K, Hannon GJ, Sawyers CL. Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screening Plos One. 7. PMID 22509301 DOI: 10.1371/Journal.Pone.0034414  0.32
2012 Cheang MC, Voduc KD, Tu D, Jiang S, Leung S, Chia SK, Shepherd LE, Levine MN, Pritchard KI, Davies S, Stijleman IJ, Davis C, Ebbert MT, Parker JS, Ellis MJ, et al. Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2402-12. PMID 22351696 DOI: 10.1158/1078-0432.Ccr-11-2956  0.599
2012 Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, Nordgard SH, Grushko T, Huo D, Nwachukwu C, Nobel A, Kristensen VN, Børresen-Dale AL, Olopade OI, Perou CM. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Research and Treatment. 133: 865-80. PMID 22048815 DOI: 10.1007/S10549-011-1846-Y  0.75
2012 Harrell JC, Prat A, Parker JS, Fan C, He X, Carey L, Anders C, Ewend M, Perou CM. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Research and Treatment. 132: 523-35. PMID 21671017 DOI: 10.1007/S10549-011-1619-7  0.564
2012 Prat A, Lluch A, Albanell J, Fang C, Lopez-Muniz JIC, Parker JS, Calvo L, Plazaola A, Lanza AA, Seguí-Palmer MA, Burgues O, Vicioso L, Sanchez-Simon R, Bermejo B, Ribelles N, et al. Gene expression-based predictors of chemotherapy response in basal-like breast cancer. Journal of Clinical Oncology. 30: 10500-10500. DOI: 10.1200/Jco.2012.30.15_Suppl.10500  0.618
2012 Smith MB, Earp HS, Parker JS, Caskey LS, Caudle AS, Calvo BF. Abstract 4527: The HER3-EREG axis and its role in colorectal cancer aggression Cancer Research. 72: 4527-4527. DOI: 10.1158/1538-7445.Am2012-4527  0.418
2012 Hoadley K, Parker J, Wilkerson, Mose L, Jefferys S, Soloway M, Turman Y, Auman J, Hayes D, Perou C. Abstract S6-1: Exploration of isoform switching and mutation expression in breast cancer by mRNA-sequencing analysis Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-S6-1  0.67
2011 Holbrook JD, Parker JS, Gallagher KT, Halsey WS, Hughes AM, Weigman VJ, Lebowitz PF, Kumar R. Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine. Journal of Translational Medicine. 9: 119. PMID 21781349 DOI: 10.1186/1479-5876-9-119  0.364
2011 Elloumi F, Hu Z, Li Y, Parker JS, Gulley ML, Amos KD, Troester MA. Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples. Bmc Medical Genomics. 4: 54. PMID 21718502 DOI: 10.1186/1755-8794-4-54  0.422
2011 Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, et al. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2342-9. PMID 21555689 DOI: 10.1200/Jco.2010.31.6950  0.425
2011 Dunbier AK, Anderson H, Ghazoui Z, Salter J, Parker JS, Perou CM, Smith IE, Dowsett M. Association between breast cancer subtypes and response to neoadjuvant anastrozole. Steroids. 76: 736-40. PMID 21447351 DOI: 10.1016/J.Steroids.2011.02.025  0.599
2011 Bivona TG, Hieronymus H, Parker J, Chang K, Taron M, Rosell R, Moonsamy P, Dahlman K, Miller VA, Costa C, Hannon G, Sawyers CL. FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. Nature. 471: 523-6. PMID 21430781 DOI: 10.1038/Nature09870  0.305
2011 Fan C, Prat A, Parker JS, Liu Y, Carey LA, Troester MA, Perou CM. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures. Bmc Medical Genomics. 4: 3. PMID 21214954 DOI: 10.1186/1755-8794-4-3  0.636
2011 Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, Perou CM. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e18-20. PMID 21115855 DOI: 10.1200/Jco.2010.28.9199  0.526
2011 Chung CH, Pohlmann PR, Rothenberg ML, Burkey BB, Parker J, Palka K, Aulino J, Puzanov I, Murphy B. Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma Head and Neck. 33: 1804-1808. PMID 20652976 DOI: 10.1002/Hed.21478  0.344
2011 Bild AH, Parker JS, Gustafson AM, Acharya CR, Hoadley KA, Anders C, Marcom PK, Carey LA, Potti A, Nevins JR, Perou CM. Correction: An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer Breast Cancer Research. 13. DOI: 10.1186/bcr2909  0.693
2010 Thorner AR, Parker JS, Hoadley KA, Perou CM. Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. Plos One. 5: e13073. PMID 20949095 DOI: 10.1371/Journal.Pone.0013073  0.795
2010 Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, Davies SR, Snider J, Stijleman IJ, Reed J, Cheang MC, Mardis ER, Perou CM, Bernard PS, Ellis MJ. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5222-32. PMID 20837693 DOI: 10.1158/1078-0432.Ccr-10-1282  0.621
2010 Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research : Bcr. 12: R68. PMID 20813035 DOI: 10.1186/Bcr2635  0.802
2010 Perou CM, Parker JS, Prat A, Ellis MJ, Bernard PS. Clinical implementation of the intrinsic subtypes of breast cancer. The Lancet. Oncology. 11: 718-9; author reply . PMID 20688274 DOI: 10.1016/S1470-2045(10)70176-5  0.586
2010 Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD, Oberthuer A, Thomas RS, Paules RS, Fielden M, ... ... Parker J, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nature Biotechnology. 28: 827-38. PMID 20676074 DOI: 10.1038/Nbt.1665  0.364
2010 Dunbier AK, Anderson H, Ghazoui Z, Folkerd EJ, A'hern R, Crowder RJ, Hoog J, Smith IE, Osin P, Nerurkar A, Parker JS, Perou CM, Ellis MJ, Dowsett M. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1161-7. PMID 20124184 DOI: 10.1200/Jco.2009.23.9616  0.583
2010 Haugen AC, Di Prospero NA, Parker JS, Fannin RD, Chou J, Meyer JN, Halweg C, Collins JB, Durr A, Fischbeck K, Van Houten B. Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. Plos Genetics. 6: e1000812. PMID 20090835 DOI: 10.1371/Journal.Pgen.1000812  0.336
2010 Korde LA, Lusa L, McShane L, Lebowitz PF, Lukes L, Camphausen K, Parker JS, Swain SM, Hunter K, Zujewski JA. Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer. Breast Cancer Research and Treatment. 119: 685-99. PMID 20012355 DOI: 10.1007/S10549-009-0651-3  0.456
2010 Sandhu R, Parker JS, Jones WD, Livasy CA, Coleman WB. Microarray-based gene expression profiling for molecular classification of breast cancer and identification of new targets for therapy Laboratory Medicine. 41: 364-372. DOI: 10.1309/Lmlik0Vie3Cjk0Wd  0.51
2010 Ellis M, Suman V, Hoog J, Lin L, Snider J, Parker J, Deshryver K, Watson M, Allred C, Hunt K, Olson J. Abstract S1-2: ACOSOG Z1031: A Randomized Neoadjuvant Comparison between Letrozole (LET), Anastrozole (ANA) and Exemestane (EXE) for Postmenopausal Women with ER Rich Stage 2/3 Breast Cancer: Biomarker Outcomes and the Predictive Value of the Baseline PAM50 Based Intrinsic Subtype Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-S1-2  0.389
2009 Bild AH, Parker JS, Gustafson AM, Acharya CR, Hoadley KA, Anders C, Marcom PK, Carey LA, Potti A, Nevins JR, Perou CM. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer. Breast Cancer Research : Bcr. 11: R55. PMID 19638211 DOI: 10.1186/Bcr2344  0.742
2009 Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y, Moses HL. Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. The Journal of Clinical Investigation. 119: 1571-82. PMID 19451693 DOI: 10.1172/Jci37480  0.421
2009 Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. Journal of the National Cancer Institute. 101: 736-50. PMID 19436038 DOI: 10.1093/Jnci/Djp082  0.639
2009 Crowder RJ, Phommaly C, Tao Y, Hoog J, Luo J, Perou CM, Parker JS, Miller MA, Huntsman DG, Lin L, Snider J, Davies SR, Olson JA, Watson MA, Saporita A, et al. PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer. Cancer Research. 69: 3955-62. PMID 19366795 DOI: 10.1158/0008-5472.Can-08-4450  0.596
2009 Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1160-7. PMID 19204204 DOI: 10.1200/Jco.2008.18.1370  0.619
2009 Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, Kocherginsky M, Parker JS, Chung CH, Rosner MR. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Research. 69: 65-74. PMID 19117988 DOI: 10.1158/0008-5472.Can-08-0377  0.33
2009 Thorner AR, Hoadley KA, Parker JS, Winkel S, Millikan RC, Perou CM. In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene. 28: 742-51. PMID 19043454 DOI: 10.1038/Onc.2008.430  0.8
2009 Harris LN, Parker J, Broadwater G, Schulz V, Halligan K, Geyda K, Seidman A, Berry D, Winer E, Hudis C, Krasnitz A, Hicks J, Tuck DP, Perou C. Genome-Wide Profiling of Archived Material from CALGB 9840 and 9342 for Paclitaxel (P) and Trastuzumab (T) Response Biomarkers Using Gene Expression and Copy Number Analysis. Cancer Research. 69: 4032-4032. DOI: 10.1158/0008-5472.Sabcs-09-4032  0.589
2009 Parker J, Prat A, Cheang M, Lenburg M, Paik S, Perou C. Breast Cancer Molecular Subtypes Predict Response to Anthracycline/Taxane-Based Chemotherapy. Cancer Research. 69: 2019-2019. DOI: 10.1158/0008-5472.Sabcs-09-2019  0.613
2009 Liu X, Parker J, Fan C, Perou CM, Marron JS. Visualization of Cross-Platform Microarray Normalization Batch Effects and Noise in Microarray Experiments: Sources and Solutions. 167-181. DOI: 10.1002/9780470685983.ch14  0.38
2008 Parker J, Mullins M, Cheang MC, Davies S, Mardis E, Nielsen TO, Ellis MJ, Marron S, Perou CM, Bernard PS. A supervised risk predictor of breast cancer based on biological subtypes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 11008. PMID 27948334 DOI: 10.1200/Jco.2008.26.15_Suppl.11008  0.549
2008 Charles PC, Alder BD, Hilliard EG, Schisler JC, Lineberger RE, Parker JS, Mapara S, Wu SS, Portbury A, Patterson C, Stouffer GA. Tobacco use induces anti-apoptotic, proliferative patterns of gene expression in circulating leukocytes of Caucasian males. Bmc Medical Genomics. 1: 38. PMID 18710571 DOI: 10.1186/1755-8794-1-38  0.321
2008 Wakamatsu N, Collins JB, Parker JS, Tessema M, Clayton NP, Ton TV, Hong HH, Belinsky S, Devereux TR, Sills RC, Lahousse SA. Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and other novel pathways contribute to the pathogenesis of cumene-induced lung tumors. Toxicologic Pathology. 36: 743-52. PMID 18648096 DOI: 10.1177/0192623308320801  0.32
2008 Wang SE, Xiang B, Guix M, Olivares MG, Parker J, Chung CH, Pandiella A, Arteaga CL. Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. Molecular and Cellular Biology. 28: 5605-20. PMID 18625725 DOI: 10.1128/Mcb.00787-08  0.373
2008 Gohlke JM, Armant O, Parham FM, Smith MV, Zimmer C, Castro DS, Nguyen L, Parker JS, Gradwohl G, Portier CJ, Guillemot F. Characterization of the proneural gene regulatory network during mouse telencephalon development. Bmc Biology. 6: 15. PMID 18377642 DOI: 10.1186/1741-7007-6-15  0.319
2008 Silva JM, Marran K, Parker JS, Silva J, Golding M, Schlabach MR, Elledge SJ, Hannon GJ, Chang K. Profiling essential genes in human mammary cells by multiplex RNAi screening Science. 319: 617-620. PMID 18239125 DOI: 10.1126/Science.1149185  0.344
2007 Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, Zeitlinger J, Adelman K. RNA polymerase is poised for activation across the genome. Nature Genetics. 39: 1507-11. PMID 17994021 DOI: 10.1038/Ng.2007.21  0.319
2007 Mullins M, Perreard L, Quackenbush JF, Gauthier N, Bayer S, Ellis M, Parker J, Perou CM, Szabo A, Bernard PS. Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues. Clinical Chemistry. 53: 1273-9. PMID 17525107 DOI: 10.1373/Clinchem.2006.083725  0.601
2006 Chung CH, Parker JS, Ely K, Carter J, Yi Y, Murphy BA, Ang KK, El-Naggar AK, Zanation AM, Cmelak AJ, Levy S, Slebos RJ, Yarbrough WG. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Research. 66: 8210-8. PMID 16912200 DOI: 10.1158/0008-5472.Can-06-1213  0.396
2006 Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, et al. The molecular portraits of breast tumors are conserved across microarray platforms. Bmc Genomics. 7: 96. PMID 16643655 DOI: 10.1186/1471-2164-7-96  0.738
2006 Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, Mone M, Hansen H, Buys SS, Rasmussen K, Orrico AR, Dreher D, Walters R, Parker J, Hu Z, et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Research : Bcr. 8: R23. PMID 16626501 DOI: 10.1186/Bcr1399  0.566
2005 Malarkey DE, Parker JS, Turman CA, Scott AM, Paules RS, Collins J, Maronpot RR. Microarray data analysis of mouse neoplasia. Toxicologic Pathology. 33: 127-35. PMID 15805064 DOI: 10.1080/01926230590888315  0.413
2004 Thomson JM, Parker J, Perou CM, Hammond SM. A custom microarray platform for analysis of microRNA gene expression Nat Methods. 1: 47-53. PMID 15782152 DOI: 10.1038/Nmeth704  0.488
2004 Troester MA, Hoadley KA, Parker JS, Perou CM. Prediction of toxicant-specific gene expression signatures after chemotherapeutic treatment of breast cell lines. Environmental Health Perspectives. 112: 1607-13. PMID 15598611 DOI: 10.1289/Txg.7204  0.671
2004 Chung CH, Parker JS, Karaca G, Wu J, Funkhouser WK, Moore D, Butterfoss D, Xiang D, Zanation A, Yin X, Shockley WW, Weissler MC, Dressler LG, Shores CG, Yarbrough WG, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 5: 489-500. PMID 15144956 DOI: 10.1016/S1535-6108(04)00112-6  0.523
2004 Benito M, Parker J, Du Q, Wu J, Xiang D, Perou CM, Marron JS. Adjustment of systematic microarray data biases. Bioinformatics (Oxford, England). 20: 105-14. PMID 14693816 DOI: 10.1093/Bioinformatics/Btg385  0.451
2003 Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the United States of America. 100: 8418-23. PMID 12829800 DOI: 10.1073/Pnas.0932692100  0.632
Low-probability matches (unlikely to be authored by this person)
2018 Conway K, Edmiston SN, Parker JS, Kuan PF, Tsai YH, Groben PA, Zedek DC, Scott GA, Parrish EA, Hao H, Pearlstein MV, Frank JS, Carson CC, Wilkerson MD, Zhao X, et al. Identification of a robust methylation classifier for cutaneous melanoma diagnosis. The Journal of Investigative Dermatology. PMID 30529013 DOI: 10.1016/J.Jid.2018.11.024  0.299
2017 Sharma MR, Auman JT, Patel NM, Grilley-Olson JE, Zhao X, Moschos SJ, Parker JS, Yin X, Hayward MC, Polite BN, Marangon E, Posocco B, Toffoli G, Hayes DN, Innocenti F. Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of and . Jco Precision Oncology. 2017. PMID 30009279  0.297
2005 Boorman GA, Blackshear PE, Parker JS, Lobenhofer EK, Malarkey DE, Vallant MK, Gerken DK, Irwin RD. Hepatic gene expression changes throughout the day in the Fischer rat: implications for toxicogenomic experiments. Toxicological Sciences : An Official Journal of the Society of Toxicology. 86: 185-93. PMID 15814895 DOI: 10.1093/Toxsci/Kfi166  0.296
2015 Montgomery ND, Parker JS, Eberhard DA, Patel NM, Weck KE, Sharpless NE, Hu Z, Hayes DN, Gulley ML. Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. PMID 26371432 DOI: 10.1097/Pai.0000000000000215  0.296
2007 Sama P, Long TC, Hester S, Tajuba J, Parker J, Chen LC, Veronesi B. The cellular and genomic response of an immortalized microglia cell line (BV2) to concentrated ambient particulate matter. Inhalation Toxicology. 19: 1079-87. PMID 17957548 DOI: 10.1080/08958370701628721  0.294
2019 Liu JY, Souroullas GP, Diekman BO, Krishnamurthy J, Hall BM, Sorrentino JA, Parker JS, Sessions GA, Gudkov AV, Sharpless NE. Cells exhibiting strong promoter activation in vivo display features of senescence. Proceedings of the National Academy of Sciences of the United States of America. PMID 30683717 DOI: 10.1073/Pnas.1818313116  0.293
2020 Giannikou K, Zhu Z, Kim J, Winden KD, Tyburczy ME, Marron D, Parker JS, Hebert Z, Bongaarts A, Taing L, Long HW, Pisano WV, Alexandrescu S, Godlewski B, Nellist M, et al. Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profile. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 33051600 DOI: 10.1038/s41379-020-00659-9  0.292
2020 Fedoriw Y, Selitsky S, Montgomery ND, Kendall SM, Richards KL, Du W, Tomoka T, Mulenga M, Parker JS, Dave SS, Gopal S. Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32080349 DOI: 10.1038/S41379-020-0506-3  0.291
2016 Galicia JC, Henson BR, Parker JS, Khan AA. Gene expression profile of pulpitis. Genes and Immunity. PMID 27052691 DOI: 10.1038/Gene.2016.14  0.291
2017 Dellon ES, Veerappan R, Selitsky SR, Parker JS, Higgins LL, Beitia R, Genta RM, Lash RH. A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults. Clinical and Translational Gastroenterology. 8: e74. PMID 28181994 DOI: 10.1038/Ctg.2017.2  0.291
2016 Wood WA, Krishnamurthy J, Mitin N, Torrice C, Parker JS, Snavely AC, Shea TC, Serody JS, Sharpless NE. Chemotherapy and Stem Cell Transplantation Increase p16(INK4a) Expression, a Biomarker of T-cell Aging. Ebiomedicine. PMID 27591832 DOI: 10.1016/J.Ebiom.2016.08.029  0.291
2019 Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B, Blumberg JM, Patel SN, Weissler MC, Yarbrough WG, Nathan C S, ... Parker J, et al. PIK3CA mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation. Journal of the National Cancer Institute. PMID 31747025 DOI: 10.1093/Jnci/Djz224  0.29
2018 Selitsky SR, Marron D, Mose LE, Parker JS, Dittmer DP. Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. Msystems. 3. PMID 30271878 DOI: 10.1128/mSystems.00081-18  0.289
2005 Powell CL, Kosyk O, Bradford BU, Parker JS, Lobenhofer EK, Denda A, Uematsu F, Nakae D, Rusyn I. Temporal correlation of pathology and DNA damage with gene expression in a choline-deficient model of rat liver injury. Hepatology (Baltimore, Md.). 42: 1137-47. PMID 16250055 DOI: 10.1002/Hep.20910  0.289
2015 Karaca M, Liu Y, Zhang Z, De Silva D, Parker JS, Earp HS, Whang YE. Mutation of androgen receptor N-terminal phosphorylation site Tyr-267 leads to inhibition of nuclear translocation and DNA binding. Plos One. 10: e0126270. PMID 25950519 DOI: 10.1371/Journal.Pone.0126270  0.287
2009 Hatakeyama H, Parker J, Wheeler D, Harari P, Levy S, Chung CH. Effect of insulin-like growth factor 1 receptor inhibitor on sensitization of head and neck cancer cells to cetuximab and methotrexate. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6079. PMID 27961955 DOI: 10.1200/Jco.2009.27.15_Suppl.6079  0.287
2019 Carper MB, Troutman S, Wagner BL, Byrd KM, Selitsky SR, Parag-Sharma K, Henry EC, Li W, Parker JS, Montgomery SA, Cleveland JL, Williams SE, Kissil JL, Hayes DN, Amelio AL. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma. Cell Reports. 29: 1660-1674.e7. PMID 31693903 DOI: 10.1016/J.Celrep.2019.10.005  0.285
2019 De Silva D, Zhang Z, Liu Y, Parker JS, Xu C, Cai L, Wang GG, Earp HS, Whang YE. Interaction between androgen receptor and coregulator SLIRP is regulated by Ack1 tyrosine kinase and androgen. Scientific Reports. 9: 18637. PMID 31819114 DOI: 10.1038/S41598-019-55057-2  0.285
2019 Chera BS, Kumar S, Beaty BT, Marron D, Jefferys SR, Green RL, Goldman EC, Amdur R, Sheets N, Dagan R, Hayes DN, Weiss J, Grilley-Olson JE, Zanation AM, Hackman TG, ... ... Parker JS, et al. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31088830 DOI: 10.1158/1078-0432.Ccr-19-0211  0.282
2018 Vora NL, Parker J, Mieczkowski P, Smeester L, Laughon M, Fry R, Boggess K. 261: RNA sequencing of umbilical cord blood to investigate gene expression in preterm birth American Journal of Obstetrics and Gynecology. 218: S167. DOI: 10.1016/J.Ajog.2017.10.189  0.282
2010 Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, Parker JS, Paddison PJ, Tam W, Ferrando A, Wendel HG. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nature Cell Biology. 12: 372-9. PMID 20190740 DOI: 10.1038/Ncb2037  0.281
2010 Connor EE, Kahl S, Elsasser TH, Parker JS, Li RW, Van Tassell CP, Baldwin RL, Barao SM. Enhanced mitochondrial complex gene function and reduced liver size may mediate improved feed efficiency of beef cattle during compensatory growth. Functional & Integrative Genomics. 10: 39-51. PMID 19777276 DOI: 10.1007/S10142-009-0138-7  0.28
2016 Dellon E, Veerappan R, Selitsky SR, Parker JS, Higgins LL, Beitia R, Genta RM, Lash RH. Mo1209 An Esophageal Biopsy Gene Expression Score Is Valid for Diagnosis and Monitoring Treatment for Eosinophilic Esophagitis in Adults Gastroenterology. 150: S672. DOI: 10.1016/S0016-5085(16)32284-3  0.28
2006 Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes & Development. 20: 2202-7. PMID 16882971 DOI: 10.1101/Gad.1444406  0.278
2019 McCann JV, Xiao L, Kim DJ, Khan OF, Kowalski PS, Anderson DG, Pecot CV, Azam SH, Parker JS, Tsai YS, Wolberg AS, Turner SD, Tatsumi K, Mackman N, Dudley AC. Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1. The Journal of Clinical Investigation. 130. PMID 30855280 DOI: 10.1172/Jci123106  0.278
2010 Tsuchiya M, Parker JS, Kono H, Matsuda M, Fujii H, Rusyn I. Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma. Molecular Cancer. 9: 74. PMID 20380719 DOI: 10.1186/1476-4598-9-74  0.277
2023 Tsai YS, Chareddy YS, Price BA, Parker JS, Pecot CV. An integrated model for predicting KRAS dependency. Plos Computational Biology. 19: e1011095. PMID 37141389 DOI: 10.1371/journal.pcbi.1011095  0.276
2018 Thomas NE, Edmiston SN, Tsai YS, Parker JS, Googe PB, Busam KJ, Scott GA, Zedek DC, Parrish EA, Hao H, Slater NA, Pearlstein MV, Frank JS, Kuan PF, Ollila DW, et al. Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis. The American Journal of Dermatopathology. PMID 30211730 DOI: 10.1097/Dad.0000000000001259  0.275
2017 Eluri S, Selitsky SR, Parker JS, Hollyfield J, Perjar I, Rusin S, Woosley JT, Lash RH, Genta RM, Dellon ES. Clinical and Molecular Predictors of Histologic Response to Topical Steroid Treatment in Eosinophilic Esophagitis: Results from a Prospective Study Gastroenterology. 152: S858. DOI: 10.1016/S0016-5085(17)32952-9  0.275
2019 Kumar S, Chera BS, Beaty B, Marron D, Jefferys S, Amdur R, Sheets N, Dagan R, Hayes DN, Weiss J, Grilley-Olson JE, Zanation AM, Hackman T, Blumberg J, Patel S, ... ... Parker JS, et al. Multiplexed digital PCR for detection of HPV in tissue samples from oropharyngeal cancer patients. Journal of Clinical Oncology. 37: e17552-e17552. DOI: 10.1200/Jco.2019.37.15_Suppl.E17552  0.274
2006 Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Molecular and Cellular Biology. 26: 9196-208. PMID 17030620 DOI: 10.1128/Mcb.00945-06  0.273
2023 Gillis N, Etheridge AS, Patil SA, Hayes DN, Hayward MC, Auman JT, Parker JS, Innocenti F. Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The Pharmacogenomics Journal. PMID 36709390 DOI: 10.1038/s41397-023-00299-7  0.273
2020 Wood CG, Ferguson JE, Parker JS, Moore DT, Whisenant JG, Maygarden SJ, Wallen EM, Kim WY, Milowsky MI, Beckermann KE, Davis NB, Haake SM, Karam JA, Bortone DS, Vincent BG, et al. Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma. Jci Insight. 5. PMID 33208553 DOI: 10.1172/jci.insight.132852  0.272
2005 Irwin RD, Parker JS, Lobenhofer EK, Burka LT, Blackshear PE, Vallant MK, Lebetkin EH, Gerken DF, Boorman GA. Transcriptional profiling of the left and median liver lobes of male f344/n rats following exposure to acetaminophen. Toxicologic Pathology. 33: 111-7. PMID 15805062 DOI: 10.1080/01926230590522257  0.272
2016 Dellon ES, Higgins LL, Beitia R, Rusin S, Woosley JT, Veerappan R, Selitsky SR, Parker JS, Genta RM, Lash RH, Aranda R, Peach RJ, Grimm M. Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis. Alimentary Pharmacology & Therapeutics. PMID 27193351 DOI: 10.1111/Apt.13672  0.268
2009 Ezhkova E, Pasolli HA, Parker JS, Stokes N, Su IH, Hannon G, Tarakhovsky A, Fuchs E. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell. 136: 1122-35. PMID 19303854 DOI: 10.1016/J.Cell.2008.12.043  0.266
2016 Lang PY, Nanjangud GJ, Sokolsky-Papkov M, Shaw C, Hwang D, Parker JS, Kabanov AV, Gershon TR. ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation. Development (Cambridge, England). 143: 4038-4052. PMID 27803059 DOI: 10.1242/Dev.139022  0.266
2018 Vora NL, Parker J, Mieczkowski P, Smeester L, Laughon M, Fry R, Boggess K. 262: Fetal immune function gene expression varies by gestational age and race American Journal of Obstetrics and Gynecology. 218: S167-S168. DOI: 10.1016/J.Ajog.2017.10.190  0.265
2018 Brady SW, McQuerry JA, Qiao Y, Piccolo SR, Shrestha G, Jenkins DF, Layer RM, Pedersen BS, Miller RH, Esch A, Selitsky SR, Parker JS, Anderson LA, Dalley BK, Factor RE, et al. Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes. Nature Communications. 9: 572. PMID 29402882 DOI: 10.1038/S41467-017-02383-6  0.264
2009 Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, Naing T, Buerki C, McLean BW, Cook RC, Parker JS, McPherson R. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 1671-7. PMID 19592466 DOI: 10.1161/Atvbaha.109.189522  0.262
2018 Xu B, Cai L, Butler JM, Chen D, Lu X, Allison DF, Lu R, Rafii S, Parker JS, Zheng D, Wang GG. The Chromatin Remodeler BPTF Activates a Stemness Gene-Expression Program Essential for the Maintenance of Adult Hematopoietic Stem Cells. Stem Cell Reports. PMID 29456179 DOI: 10.1016/J.Stemcr.2018.01.020  0.262
2020 Bortone DS, Woodcock MG, Parker JS, Vincent BG. Improved T cell receptor diversity estimates associate with survival and response to anti-PD-1 therapy. Cancer Immunology Research. PMID 33177107 DOI: 10.1158/2326-6066.CIR-20-0398  0.261
2018 Slater N, Bowers E, Parker J, Eberhard D, Earp S, Ollila D, Moschos S, Hayes N, Thomas N. Targeted sequencing identified many potentially actionable mutations in melanoma Journal of the American Academy of Dermatology. 79. DOI: 10.1016/J.Jaad.2018.05.1105  0.26
2007 Thomson JM, Parker JS, Hammond SM. Microarray analysis of miRNA gene expression. Methods in Enzymology. 427: 107-22. PMID 17720481 DOI: 10.1016/S0076-6879(07)27006-5  0.258
2010 Fannin RD, Russo M, O'Connell TM, Gerrish K, Winnike JH, Macdonald J, Newton J, Malik S, Sieber SO, Parker J, Shah R, Zhou T, Watkins PB, Paules RS. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology (Baltimore, Md.). 51: 227-36. PMID 19918972 DOI: 10.1002/Hep.23330  0.257
2014 Rager JE, Bailey KA, Smeester L, Miller SK, Parker JS, Laine JE, Drobná Z, Currier J, Douillet C, Olshan AF, Rubio-Andrade M, Stýblo M, García-Vargas G, Fry RC. Prenatal arsenic exposure and the epigenome: altered microRNAs associated with innate and adaptive immune signaling in newborn cord blood. Environmental and Molecular Mutagenesis. 55: 196-208. PMID 24327377 DOI: 10.1002/Em.21842  0.257
2015 Stasulli NM, Eichelberger KR, Price PA, Pechous RD, Montgomery SA, Parker JS, Goldman WE. Spatially Distinct Neutrophil Responses within the Inflammatory Lesions of Pneumonic Plague. Mbio. 6. PMID 26463167 DOI: 10.1128/Mbio.01530-15  0.256
2020 Orlando KA, Douglas AK, Abudu A, Wang Y, Tessier-Cloutier B, Su W, Peters A, Sherman LS, Moore R, Nguyen V, Negri GL, Colborne S, Morin GB, Kommoss F, Lang JD, ... ... Parker JS, et al. Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. Elife. 9. PMID 33355532 DOI: 10.7554/eLife.59073  0.256
2021 Pierce SR, Fang Z, Yin Y, West L, Asher M, Hao T, Zhang X, Tucker K, Staley A, Fan Y, Sun W, Moore DT, Xu C, Tsai YH, Parker J, et al. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer. Journal of Experimental & Clinical Cancer Research : Cr. 40: 61. PMID 33557912 DOI: 10.1186/s13046-021-01842-9  0.255
2018 Chason KD, Jaspers I, Parker J, Sellers S, Brighton LE, Hunsucker SA, Armistead PM, Fischer WA. Age-associated Changes in the Respiratory Epithelial Response to Influenza Infection. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 29878083 DOI: 10.1093/Gerona/Gly126  0.254
2010 Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, Baumann J, Burkey B, Netterville J, Sinard R, Yarbrough WG, Cmelak AJ, Slebos RJ, Shyr Y, Parker J, Gilbert J, Murphy BA. Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 864-70. PMID 19850643 DOI: 10.1093/Annonc/Mdp390  0.253
2017 Garber ME, Saldanha A, Parker JS, Jones WD, Kaukinen K, Laurila K, Lähdeaho ML, Khatri P, Khosla C, Adelman DC, Mäki M. A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease. Cellular and Molecular Gastroenterology and Hepatology. 4: 1-17. PMID 28508029 DOI: 10.1016/J.Jcmgh.2017.01.011  0.253
2009 Uziel T, Karginov FV, Xie S, Parker JS, Wang YD, Gajjar A, He L, Ellison D, Gilbertson RJ, Hannon G, Roussel MF. The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 2812-7. PMID 19196975 DOI: 10.1073/Pnas.0809579106  0.253
2007 Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biology. 8: R27. PMID 17326821 DOI: 10.1186/Gb-2007-8-2-R27  0.248
2018 Linnstaedt SD, Riker KD, Rueckeis CA, Kutchko KM, Lackey L, McCarthy KR, Tsai YH, Parker JS, Kurz MC, Hendry PL, Lewandowski C, Datner E, Pearson C, O'Neil B, Domeier R, et al. A functional riboSNitch in the 3'UTR of alters microRNA-320a binding efficiency and mediates vulnerability to chronic posttraumatic pain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30150364 DOI: 10.1523/Jneurosci.3458-17.2018  0.246
2019 Xing T, Benderman LJ, Sabu S, Parker J, Yang J, Lu Q, Ding L, Chen YH. Tight junction protein claudin-7 is essential for intestinal epithelial stem cell self-renewal and differentiation. Cellular and Molecular Gastroenterology and Hepatology. PMID 31874254 DOI: 10.1016/J.Jcmgh.2019.12.005  0.243
2019 Engle ML, Monk JN, Jania CM, Martin JR, Gomez JC, Dang H, Parker JS, Doerschuk CM. Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice. Plos One. 14: e0212866. PMID 30818335 DOI: 10.1371/Journal.Pone.0212866  0.243
2022 Tsai YS, Woodcock MG, Azam SH, Thorne LB, Kanchi KL, Parker JS, Vincent BG, Pecot CV. Rapid idiosyncratic mechanisms of clinical resistance to KRAS G12C inhibition. The Journal of Clinical Investigation. PMID 34990404 DOI: 10.1172/JCI155523  0.239
2017 Kardos J, Wobker SE, Woods ME, Nielsen ME, Smith AB, Wallen EM, Pruthi RS, Hayward MC, McGinty KA, Grilley-Olson JE, Patel NM, Weck KE, Black P, Parker JS, Milowsky MI, et al. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype. Jco Precision Oncology. 1. PMID 32913973 DOI: 10.1200/PO.17.00027  0.236
2015 Linnstaedt SD, Walker MG, Parker JS, Yeh E, Sons RL, Zimny E, Lewandowski C, Hendry PL, Damiron K, Pearson C, Velilla MA, O'Neil BJ, Jones J, Swor R, Domeier R, et al. MicroRNA circulating in the early aftermath of motor vehicle collision predict persistent pain development and suggest a role for microRNA in sex-specific pain differences. Molecular Pain. 11: 66. PMID 26498117 DOI: 10.1186/S12990-015-0069-3  0.235
2018 Dvorak CC, Satwani P, Stieglitz E, Cairo MS, Dang H, Pei Q, Gao Y, Wall D, Mazor T, Olshen AB, Parker JS, Kahwash S, Hirsch B, Raimondi S, Patel N, et al. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatric Blood & Cancer. PMID 29528181 DOI: 10.1002/Pbc.27034  0.233
2021 Marcel SS, Quimby AL, Noel MP, Jaimes OC, Mehrab-Mohseni M, Ashur SA, Velasco B, Tsuruta JK, Kasoji SK, Santos CM, Dayton PA, Parker JS, Davis IJ, Pattenden SG. Genome-wide cancer-specific chromatin accessibility patterns derived from archival processed xenograft tumors. Genome Research. PMID 34815311 DOI: 10.1101/gr.275219.121  0.23
2007 Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, Hannon GJ. A biochemical approach to identifying microRNA targets. Proceedings of the National Academy of Sciences of the United States of America. 104: 19291-6. PMID 18042700 DOI: 10.1073/Pnas.0709971104  0.23
2017 Beak J, Huang W, Parker JS, Hicks ST, Patterson C, Simpson PC, Ma A, Jin J, Jensen BC. An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity. Jacc. Basic to Translational Science. 2: 39-53. PMID 28286875 DOI: 10.1016/J.Jacbts.2016.10.006  0.23
2019 Jaworski L, Griffith K, Mancini B, Jolly S, Boike T, Moran J, Dominello M, Wilson M, Parker J, Burmeister J, Gardner S, Fraser C, Miller L, Baldwin K, Mietzel M, et al. Contemporary Practice Patterns for Radiotherapy of Bone Metastases: Preliminary Analysis of Prospective Data from a Statewide Consortium Focusing on Extended Fractionation International Journal of Radiation Oncology*Biology*Physics. 105: S153. DOI: 10.1016/J.Ijrobp.2019.06.162  0.229
2009 Schisler JC, Charles PC, Parker JS, Hilliard EG, Mapara S, Meredith D, Lineberger RE, Wu SS, Alder BD, Stouffer GA, Patterson C. Stable patterns of gene expression regulating carbohydrate metabolism determined by geographic ancestry. Plos One. 4: e8183. PMID 20016837 DOI: 10.1371/Journal.Pone.0008183  0.225
2017 Willis MS, Holley DW, Wang Z, Chen X, Quintana M, Jensen BC, Tannu M, Parker J, Jeyaraj D, Jain MK, Wolfram JA, Lee HG, Bultman SJ. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility. Journal of Molecular and Cellular Cardiology. PMID 28232072 DOI: 10.1016/J.Yjmcc.2017.02.003  0.222
2018 Gunasekara D, Speer J, Wang Y, Nguyen DL, Reed MI, Smiddy NM, Parker JS, Fallon JK, Smith PC, Sims CE, Magness ST, Allbritton NL. A monolayer of primary colonic epithelium generated on a scaffold with a gradient of stiffness for drug transport studies. Analytical Chemistry. PMID 30350627 DOI: 10.1021/Acs.Analchem.8B02845  0.221
2022 Dellon ES, Tsai YS, Coffey AR, Bodwin K, Sninsky JA, Mosso CN, He TM, O'Connor KA, Selitsky SR, Nobel AB, Parker JS. Pre-treatment differential correlation of gene expression and response to topical steroids in eosinophilic esophagitis. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus. PMID 36222072 DOI: 10.1093/dote/doac071  0.22
2014 Linnstaedt S, Walker M, Parker J, Sons R, Velilla M, Pearson C, O'Neil B, Zimny E, Lewandowski C, Damiron K, Hendry P, Barnes S, Rosenberg M, Hammond S, McLean S. (269) Circulating microRNA evaluated in the early aftermath of motor vehicle collision predict widespread pain development in African Americans and provide potential pathogenic insights: results of a preliminary analysis The Journal of Pain. 15: S43. DOI: 10.1016/J.Jpain.2014.01.178  0.219
2015 Simon JM, Parker JS, Liu F, Rothbart SB, Ait-Si-Ali S, Strahl BD, Jin J, Davis IJ, Mosley AL, Pattenden SG. A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin. The Journal of Biological Chemistry. 290: 26088-102. PMID 26338712 DOI: 10.1074/Jbc.M115.654459  0.219
2022 Li H, Harrison EB, Li H, Hirabayashi K, Chen J, Li QX, Gunn J, Weiss J, Savoldo B, Parker JS, Pecot CV, Dotti G, Du H. Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration. Nature Communications. 13: 2154. PMID 35443752 DOI: 10.1038/s41467-022-29647-0  0.215
2002 Moore JH, Parker JS, Olsen NJ, Aune TM. Symbolic discriminant analysis of microarray data in autoimmune disease. Genetic Epidemiology. 23: 57-69. PMID 12112248 DOI: 10.1002/Gepi.1117  0.21
2021 Conway K, Tsai YS, Edmiston SN, Parker JS, Parrish EA, Hao H, Kuan PF, Scott GA, Frank JS, Googe P, Ollila DW, Thomas NE. Characterization of the CpG island hypermethylated phenotype (CIMP) subclass in primary melanomas. The Journal of Investigative Dermatology. PMID 34843679 DOI: 10.1016/j.jid.2021.11.017  0.209
2014 Li M, Jia C, Kazmierkiewicz KL, Bowman AS, Tian L, Liu Y, Gupta NA, Gudiseva HV, Yee SS, Kim M, Dentchev T, Kimble JA, Parker JS, Messinger JD, Hakonarson H, et al. Comprehensive analysis of gene expression in human retina and supporting tissues. Human Molecular Genetics. 23: 4001-14. PMID 24634144 DOI: 10.1093/Hmg/Ddu114  0.207
2021 Musicant AM, Parag-Sharma K, Gong W, Sengupta M, Chatterjee A, Henry EC, Tsai YH, Hayward MC, Sheth S, Betancourt R, Hackman TG, Padilla RJ, Parker JS, Giudice J, Flaveny CA, et al. CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition. Cell Reports. 34: 108768. PMID 33626346 DOI: 10.1016/j.celrep.2021.108768  0.205
2007 Long TC, Tajuba J, Sama P, Saleh N, Swartz C, Parker J, Hester S, Lowry GV, Veronesi B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environmental Health Perspectives. 115: 1631-7. PMID 18007996 DOI: 10.1289/Ehp.10216  0.198
2019 Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Parker JS, et al. The Immune Landscape of Cancer. Immunity. 51: 411-412. PMID 31433971 DOI: 10.1016/J.Immuni.2019.08.004  0.194
2002 Maas K, Chan S, Parker J, Slater A, Moore J, Olsen N, Aune TM. Cutting edge: molecular portrait of human autoimmune disease. Journal of Immunology (Baltimore, Md. : 1950). 169: 5-9. PMID 12077221 DOI: 10.4049/Jimmunol.169.1.5  0.194
2021 Xu C, Tsai YH, Galbo PM, Gong W, Storey AJ, Xu Y, Byrum SD, Xu L, Whang YE, Parker JS, Mackintosh SG, Edmondson RD, Tackett AJ, Huang J, Zheng D, et al. Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer. Nucleic Acids Research. PMID 33849067 DOI: 10.1093/nar/gkab252  0.192
2004 Aune TM, Maas K, Parker J, Moore JH, Olsen NJ. Profiles of gene expression in human autoimmune disease. Cell Biochemistry and Biophysics. 40: 81-96. PMID 15054216 DOI: 10.1385/Cbb:40:2:081  0.191
2006 Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, et al. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4170-6. PMID 16943533 DOI: 10.1200/JCO.2006.07.2587  0.186
2005 Boorman GA, Irwin RD, Vallant MK, Gerken DK, Lobenhofer EK, Hejtmancik MR, Hurban P, Brys AM, Travlos GS, Parker JS, Portier CJ. Variation in the hepatic gene expression in individual male Fischer rats. Toxicologic Pathology. 33: 102-10. PMID 15805061 DOI: 10.1080/01926230590522211  0.184
2007 Chung CH, Parker J, Levy S, Slebos RJ, Dicker AP, Rodeck U. Gene expression profiles as markers of aggressive disease-EGFR as a factor. International Journal of Radiation Oncology, Biology, Physics. 69: S102-5. PMID 17848272 DOI: 10.1016/j.ijrobp.2007.05.039  0.178
2021 Schrank TP, Lenze N, Landess LP, Hoyle A, Parker J, Lal A, Sheth S, Chera BS, Patel SN, Hackman TG, Major MB, Issaeva N, Yarbrough WG. Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx. Cancer. PMID 33819343 DOI: 10.1002/cncr.33504  0.173
2004 Aune TM, Parker JS, Maas K, Liu Z, Olsen NJ, Moore JH. Co-localization of differentially expressed genes and shared susceptibility loci in human autoimmunity. Genetic Epidemiology. 27: 162-72. PMID 15305332 DOI: 10.1002/Gepi.20013  0.172
2008 Chung CH, Aulino J, Parker J, Cmelak AJ, Netterville J, Burkey B, Sinard R, Yarbrough WG, Murphy BA, Gilbert J. Gene expression profile of pemetrexed and oxaliplatin response in a phase II induction trial in locally advanced head and neck squamous cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 6039. PMID 27950532 DOI: 10.1200/jco.2008.26.15_suppl.6039  0.17
2020 Eichelberger KR, Sepúlveda VE, Ford J, Selitsky SR, Mieczkowski PA, Parker JS, Goldman WE. Tn-Seq Analysis Identifies Genes Important for Yersinia pestis Adherence during Primary Pneumonic Plague. Msphere. 5. PMID 32759339 DOI: 10.1128/mSphere.00715-20  0.164
2022 Bowers LW, Doerstling SS, Shamsunder MG, Lineberger CG, Rossi EL, Montgomery SA, Coleman MF, Gong W, Parker JS, Howell A, Harvie M, Hursting SD. Reversing the genomic, epigenetic and triple negative breast cancer-enhancing effects of obesity. Cancer Prevention Research (Philadelphia, Pa.). PMID 35696725 DOI: 10.1158/1940-6207.CAPR-22-0113  0.162
2019 Cheng Z, Combs M, Zhu Q, Xia P, Opheim Z, Parker J, Mack CP, Taylor JM. Genome-Wide RNAi Screen Identifies Regulators of Cardiomyocyte Necrosis. Acs Pharmacology & Translational Science. 2: 361-371. PMID 32259070 DOI: 10.1021/acsptsci.9b00052  0.161
2024 Souroullas GP, Jeck WR, Parker JS, Simon JM, Liu JY, Paulk J, Xiong J, Clark KS, Fedoriw Y, Qi J, Burd CE, Bradner JE, Sharpless NE. Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nature Medicine. PMID 38383796 DOI: 10.1038/s41591-024-02867-1  0.15
2023 Camp K, Coleman MF, McFarlane T, Doerstling SS, Khatib SA, Rezeli ET, Lewis AG, Pfeil AJ, Smith LA, Bowers LW, Fouladi F, Gong W, Glenny EM, Parker JS, Milne GL, et al. Calorie restriction outperforms bariatric surgery in a murine model of obesity and triple-negative breast cancer. Jci Insight. PMID 37698918 DOI: 10.1172/jci.insight.172868  0.15
2023 Sninsky JA, Tsai YS, Liu S, Parker JS, Corcoran D, Dellon ES. Peripheral blood IL5RA gene expression as a diagnostic biomarker for eosinophilic esophagitis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 37944574 DOI: 10.1016/j.cgh.2023.10.028  0.147
2022 Wiedner HJ, Torres EV, Blue RE, Tsai YH, Parker J, Giudice J. SET domain containing 2 (SETD2) Influences Metabolism and Alternative Splicing During Myogenesis. The Febs Journal. PMID 35724320 DOI: 10.1111/febs.16553  0.142
2021 Hieronymus K, Dorschner B, Schulze F, Vora NL, Parker JS, Winkler JL, Rösen-Wolff A, Winkler S. Validation of reference genes for whole blood gene expression analysis in cord blood of preterm and full-term neonates and peripheral blood of healthy adults. Bmc Genomics. 22: 489. PMID 34193041 DOI: 10.1186/s12864-021-07801-0  0.137
2022 Hinkle E, Wiedner H, Torres E, Jackson M, Black A, Blue E, Harris S, Guzman B, Gentile G, Lee E, Tsai YH, Parker J, Dominguez D, Giudice J. Alternative splicing regulation of membrane trafficking genes during myogenesis. Rna (New York, N.Y.). PMID 35082143 DOI: 10.1261/rna.078993.121  0.134
2010 Pesavento PA, Stokol T, Liu H, van der List DA, Gaffney PM, Parker JS. Distribution of the feline calicivirus receptor junctional adhesion molecule a in feline tissues. Veterinary Pathology. 48: 361-8. PMID 20634409 DOI: 10.1177/0300985810375245  0.13
2009 Hester SD, Reid L, Nowak N, Jones WD, Parker JS, Knudtson K, Ward W, Tiesman J, Denslow ND. Comparison of comparative genomic hybridization technologies across microarray platforms. Journal of Biomolecular Techniques : Jbt. 20: 135-51. PMID 19503625  0.13
2024 Ramirez-Arcos S, Kumaran D, Cap A, Cardenas KM, Cloutier M, Ferdin J, Gravemann U, Ketter P, Landry P, Lu T, Niekerk T, Parker J, Renke C, Seltsam A, Stafford B, et al. Proliferation of psychrotrophic bacteria in cold-stored platelet concentrates. Vox Sanguinis. PMID 38631895 DOI: 10.1111/vox.13640  0.12
2022 Hinkle ER, Blue RE, Tsai YH, Combs M, Davi J, Coffey AR, Boriek AM, Taylor JM, Parker JS, Giudice J. Stretching muscle cells induces transcriptional and splicing transitions and changes in SR proteins. Communications Biology. 5: 987. PMID 36123433 DOI: 10.1038/s42003-022-03915-7  0.117
2021 Jefferys SR, Burgos SD, Peterson JJ, Selitsky SR, Turner AM, James LI, Tsai YH, Coffey AR, Margolis DM, Parker J, Browne EP. Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors. Plos Pathogens. 17: e1009346. PMID 33635929 DOI: 10.1371/journal.ppat.1009346  0.111
2023 Sanz M, Weideman AMK, Ward AR, Clohosey ML, Garcia-Recio S, Selitsky SR, Mann BT, Iannone MA, Whitworth CP, Chitrakar A, Garrido C, Kirchherr J, Coffey AR, Tsai YH, Samir S, ... ... Parker JS, et al. Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1. Frontiers in Immunology. 14: 1219250. PMID 37744358 DOI: 10.3389/fimmu.2023.1219250  0.11
2023 Sanz M, Weideman AMK, Ward AR, Clohosey ML, Garcia-Recio S, Selitsky SR, Mann BT, Iannone MA, Whitworth CP, Chitrakar A, Garrido C, Kirchherr J, Coffey AR, Tsai YH, Samir S, ... ... Parker JS, et al. Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1. Biorxiv : the Preprint Server For Biology. PMID 36798291 DOI: 10.1101/2023.02.07.527421  0.11
2007 Mori K, Blackshear PE, Lobenhofer EK, Parker JS, Orzech DP, Roycroft JH, Walker KL, Johnson KA, Marsh TA, Irwin RD, Boorman GA. Hepatic transcript levels for genes coding for enzymes associated with xenobiotic metabolism are altered with age. Toxicologic Pathology. 35: 242-51. PMID 17366318 DOI: 10.1080/01926230601156286  0.105
2015 Jang TS, Parker JS, Weiss-Schneeweiss H. Structural polymorphisms and distinct genomic composition suggest recurrent origin and ongoing evolution of B chromosomes in the Prospero autumnale complex (Hyacinthaceae). The New Phytologist. PMID 26643365 DOI: 10.1111/nph.13778  0.102
2003 Ritchie MD, White BC, Parker JS, Hahn LW, Moore JH. Optimization of neural network architecture using genetic programming improves detection and modeling of gene-gene interactions in studies of human diseases. Bmc Bioinformatics. 4: 28. PMID 12846935 DOI: 10.1186/1471-2105-4-28  0.101
2013 Singh J, Greer PB, White MA, Parker J, Patterson J, Tang CI, Capp A, Wratten C, Denham JW. Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers. International Journal of Radiation Oncology, Biology, Physics. 85: 1018-23. PMID 23040222 DOI: 10.1016/j.ijrobp.2012.07.2376  0.096
2007 Roberts A, McMillan L, Wang W, Parker J, Rusyn I, Threadgill D. Inferring missing genotypes in large SNP panels using fast nearest-neighbor searches over sliding windows. Bioinformatics (Oxford, England). 23: i401-7. PMID 17646323 DOI: 10.1093/bioinformatics/btm220  0.092
2021 Richardson H, Kumar M, Tieu MT, Parker J, Dowling JA, Arm J, Best L, Greer PB, Clapham M, Oldmeadow C, O'Connor L, Wratten C. Assessing the impact of magnetic resonance treatment simulation (MRSIM) on target volume delineation and dose to organs at risk for oropharyngeal radiotherapy. Journal of Medical Radiation Sciences. PMID 34676994 DOI: 10.1002/jmrs.552  0.092
2013 Parizotto EA, Lowe ED, Parker JS. Structural basis for duplex RNA recognition and cleavage by Archaeoglobus fulgidus C3PO Nature Structural and Molecular Biology. 20: 380-386. PMID 23353787 DOI: 10.1038/nsmb.2487  0.092
1994 Chakravarti B, Herring TA, Lass JH, Parker JS, Bucy RP, Diaconu E, Tseng J, Whitfield DR, Greene BM, Chakravarti DN. Infiltration of CD4+ T cells into cornea during development of Onchocerca volvulus-induced experimental sclerosing keratitis in mice. Cellular Immunology. 159: 306-14. PMID 7994762 DOI: 10.1006/cimm.1994.1316  0.073
2014 Rathmell WK, Brooks SA, Parker JS, Nielsen ME. Reply to Alexander S. Parker, Brad C. Leibovich, Jeanette E. Eckel-Passow, John C. Cheville's Letter to the Editor re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma. Eur Urol 2014;66:77-84 European Urology. DOI: 10.1016/j.eururo.2014.07.002  0.073
2011 Greer PB, Dowling JA, Lambert JA, Fripp J, Parker J, Denham JW, Wratten C, Capp A, Salvado O. A magnetic resonance imaging-based workflow for planning radiation therapy for prostate cancer. The Medical Journal of Australia. 194: S24-7. PMID 21401484  0.071
2013 Plüddemann A, Dada S, Parry CDH, Kader R, Parker JS, Temmingh H, Van Heerden S, De Clercq C, Lewis I. Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa African Journal of Psychiatry (South Africa). 16: 45-49. PMID 23417636 DOI: 10.4314/ajpsy.v16i1.8  0.071
2015 Parker JS, van Dijk K, Melles GR. Treatment options for advanced keratoconus: A review. Survey of Ophthalmology. PMID 26077628 DOI: 10.1016/j.survophthal.2015.02.004  0.068
2021 Yu X, Li D, Kottur J, Shen Y, Kim HS, Park KS, Tsai YH, Gong W, Wang J, Suzuki K, Parker J, Herring L, Kaniskan HÜ, Cai L, Jain R, et al. A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. Science Translational Medicine. 13: eabj1578. PMID 34586829 DOI: 10.1126/scitranslmed.abj1578  0.068
2022 Hinkle ER, Blue RE, Tsai YH, Combs M, Davi J, Coffey AR, Boriek AM, Taylor JM, Parker JS, Giudice J. Author Correction: Stretching muscle cells induces transcriptional and splicing transitions and changes in SR proteins. Communications Biology. 5: 1080. PMID 36216866 DOI: 10.1038/s42003-022-04064-7  0.058
1996 Chakravarti B, Lagoo-Deenadayalan S, Parker JS, Whitfield DR, Lagoo A, Chakravarti DN. In vivo molecular analysis of cytokines in a murine model of ocular onchocerciasis. I. Up-regulation of IL-4 and IL-5 mRNAs and not IL-2 and IFN gamma mRNAs in the cornea due to experimental interstitial keratitis. Immunology Letters. 54: 59-64. PMID 9030983 DOI: 10.1016/S0165-2478(96)02648-X  0.058
2012 Parker JS, Wilson RS, LeJeune JT, Doohan D. Including growers in the "food safety" conversation: Enhancing the design and implementation of food safety programming based on farm and marketing needs of fresh fruit and vegetable producers Agriculture and Human Values. 29: 303-319. DOI: 10.1007/S10460-012-9360-3  0.052
2014 Anthony W, Larsen A, Butcher EA, Parker JS. Impulsive guidance for optimal manifold-based transfers to earth-moon L1 halo orbits Advances in the Astronautical Sciences. 150: 761-777.  0.051
2013 Lu M, Park HC, Sivananthan A, Parker JS, Bloch E, Johansson LA, Rodwell MJW, Coldren LA. Monolithic integration of a high-speed widely tunable optical coherent receiver Ieee Photonics Technology Letters. 25: 1077-1080. DOI: 10.1109/Lpt.2013.2259474  0.047
2013 Lu M, Park HC, Bloch E, Sivananthan A, Parker JS, Griffith Z, Johansson LA, Rodwell MJW, Coldren LA. An integrated 40 Gbit/s optical costas receiver Journal of Lightwave Technology. 31: 2244-2253. DOI: 10.1109/Jlt.2013.2265075  0.046
2023 LaFleur B, Curiel-Lewandrowski C, Tapia E, Parker J, White L, Chow HS, South AP. Characterizing dermal transcriptional change in the progression from sun-protected skin to actinic keratosis. The Journal of Investigative Dermatology. PMID 36708948 DOI: 10.1016/j.jid.2022.12.021  0.045
2013 Lu M, Park HC, Parker JS, Bloch E, Sivananthan A, Griffith Z, Johansson LA, Rodwell MJ, Coldren LA. A heterodyne optical phase-locked loop for multiple applications Optical Fiber Communication Conference, Ofc 2013. OW3D.1.  0.045
2013 Parker JS, Anderson RL. Targeting low-energy transfers to low lunar orbit Acta Astronautica. 84: 1-14. DOI: 10.1016/J.Actaastro.2012.10.033  0.044
2014 Anthony W, Butcher EA, Parker JS. Statistical fuel budgets for impulsive guidance to earth-moon l1 halo orbits Aiaa/Aas Astrodynamics Specialist Conference 2014.  0.043
2014 Parker JS. Establishing a network of lunar landers via low-energy transfers Advances in the Astronautical Sciences. 152: 3737-3757.  0.042
2012 Anderson RL, Parker JS. Survey of ballistic transfers to the lunar surface Journal of Guidance, Control, and Dynamics. 35: 1256-1267. DOI: 10.2514/1.54830  0.042
2016 Liu W, Li M, Guzzon RS, Norberg EJ, Parker JS, Lu M, Coldren LA, Yao J. A fully reconfigurable photonic integrated signal processor Nature Photonics. DOI: 10.1038/Nphoton.2015.281  0.041
2014 Liu W, Li M, Guzzon RS, Norberg EJ, Parker JS, Coldren LA, Yao J. A photonic temporal integrator with an ultra-long integration time window based on an inp-ingaasp integrated ring resonator Journal of Lightwave Technology. 32: 3654-3659. DOI: 10.1109/Jlt.2014.2323249  0.041
2012 Parker JS, Wilson RS, LeJeune JT, Rivers L, Doohan D. An expert guide to understanding grower decisions related to fresh fruit and vegetable contamination prevention and control Food Control. 26: 107-116. DOI: 10.1016/J.Foodcont.2011.12.025  0.04
2013 McGranaghan RM, Leonard JM, Fujimoto K, Parker JS, Anderson RL, Born GH. Interplanetary departure stage navigation by means of LiAISON orbit determination architecture Advances in the Astronautical Sciences. 148: 97-116.  0.039
2015 Chugani DC, Chugani HT, Wiznitzer M, Parikh S, Evans PA, Hansen RL, Nass R, Janisse JJ, Dixon-Thomas P, Behen M, Rothermel R, Parker JS, Kumar A, Muzik O, Edwards DJ, et al. Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial. The Journal of Pediatrics. PMID 26746121 DOI: 10.1016/J.Jpeds.2015.11.033  0.038
2014 Parker JS. Thoughts on "human-centered veterinary medicine". Journal of the American Veterinary Medical Association. 245: 883. PMID 25285926 DOI: 10.2460/javma.245.8.883  0.038
2013 Parker JS. Integrating culture and community into environmental policy: Community tradition and farm size in conservation decision making Agriculture and Human Values. 30: 159-178. DOI: 10.1007/s10460-012-9392-8  0.037
2012 Dowling JA, Lambert J, Parker J, Salvado O, Fripp J, Capp A, Wratten C, Denham JW, Greer PB. An atlas-based electron density mapping method for magnetic resonance imaging (MRI)-alone treatment planning and adaptive MRI-based prostate radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 83: e5-11. PMID 22330995 DOI: 10.1016/j.ijrobp.2011.11.056  0.036
2013 Parrish N, Parker JS, Bradley BK. GEO observability from Earth-Moon libration point orbits Advances in the Astronautical Sciences. 148: 685-702.  0.035
2014 McGranaghan RM, Leonard JM, Parker JS, Born GH, Dietrich A, Hesar SG. Liaison tracking for a lunar far-side sample return mission Advances in the Astronautical Sciences. 152: 3175-3194.  0.035
2021 Lutrick K, Ellingson KD, Baccam Z, Rivers P, Beitel S, Parker J, Hollister J, Sun X, Gerald JK, Komatsu K, Kim E, LaFleur B, Grant L, Yoo YM, Kumar A, et al. COVID-19 Infection, Reinfection, and Vaccine Effectiveness in a Prospective Cohort of Arizona Frontline/Essential Workers: The AZ HEROES Research Protocol. Jmir Research Protocols. PMID 34057904 DOI: 10.2196/28925  0.034
2015 Sun J, Dowling J, Pichler P, Menk F, Rivest-Henault D, Lambert J, Parker J, Arm J, Best L, Martin J, Denham JW, Greer PB. MRI simulation: end-to-end testing for prostate radiation therapy using geometric pelvic MRI phantoms. Physics in Medicine and Biology. 60: 3097-109. PMID 25803177 DOI: 10.1088/0031-9155/60/8/3097  0.034
2012 Parker JS, Sivananthan A, Norberg E, Coldren LA. Regrowth-free high-gain InGaAsP/InP active-passive platform via ion implantation. Optics Express. 20: 19946-55. PMID 23037047 DOI: 10.1364/Oe.20.019946  0.034
1991 Parker JS, Gottsch JD. An Update on the Treatment of Gonococcal Ophthalmia Archives of Ophthalmology. 109: 613-614. PMID 1902659 DOI: 10.1001/archopht.1991.01080050019009  0.034
2013 Parker JS, Anderson RL, Peterson A. Surveying ballistic transfers to low lunar orbit Journal of Guidance, Control, and Dynamics. 36: 1501-1511. DOI: 10.2514/1.55661  0.033
2015 Hesar SG, Parker JS, Mcmahon J, Born GH. Small body gravity field estimation using liaison supplemented optical navigation Advances in the Astronautical Sciences. 154: 41-54.  0.033
2014 Herman JFC, Jones BA, Born GH, Parker JS. A comparison of implicit integration methods for astrodynamics Advances in the Astronautical Sciences. 150: 2957-2974.  0.033
2014 Handzo RE, Parker JS, Born GH, Smith AM. Signals of opportunity navigation in cislunar space Aiaa/Aas Astrodynamics Specialist Conference 2014.  0.033
2014 Masanovic ML, Estrella SB, Parker JS, Johansson LA. A photonic integrated circuit based optical mesh node for avionic WDM optical networks 2014 Ieee Avionics, Fiber-Optics and Photonics Technology Conference, Avfop 2014. 71-72. DOI: 10.1109/AVFOP.2014.6999429  0.033
2013 Anderson RL, Parker JS. Comparison of low-energy lunar transfer trajectories to invariant manifolds Celestial Mechanics and Dynamical Astronomy. 115: 311-331. DOI: 10.1007/S10569-012-9466-3  0.032
2013 Murray PM, Bower JF, Cox DK, Galbraith EK, Parker JS, Sweeney JB. A robust first-pass protocol for the heck-mizoroki reaction Organic Process Research and Development. 17: 397-405. DOI: 10.1021/Op300364P  0.031
2014 Handzo RE, Parker JS, Born GH, Gold KL. Using signals of opportunity in deep space satellite navigation: Breadth of coverage and solution accuracy Advances in the Astronautical Sciences. 150: 1899-1918.  0.031
2012 Parker JS, Sivananthan A, Lu M, Johansson L, Coldren LA. Integrated phase-locked multi-THz comb for broadband offset locking Optics Infobase Conference Papers.  0.03
2014 Parker JS, McElrath TP, Anderson RL, Sweetser TH. Trajectory design for moonrise: A proposed lunar south pole-aitken basin sample return mission Advances in the Astronautical Sciences. 150: 2677-2696.  0.028
2009 Parker J. Soapbox: in defence of weakness. Clinical Child Psychology and Psychiatry. 14: 145-9. PMID 19103711 DOI: 10.1177/1359104508100140  0.028
2012 Logan AW, Parker JS, Hallside MS, Burton JW. Manganese(III) acetate mediated oxidative radical cyclizations. Toward vicinal all-carbon quaternary stereocenters. Organic Letters. 14: 2940-3. PMID 22662754 DOI: 10.1021/Ol300625U  0.028
2021 Lutrick K, Groom H, Fowlkes AL, Groover KD, Gaglani M, Rivers P, Naleway AL, Nguyen K, Herring M, Dunnigan K, Phillips A, Parker J, Mayo Lamberte J, Prather K, Thiese MS, et al. COVID-19 vaccine perceptions and uptake in a national prospective cohort of essential workers. Vaccine. PMID 34906392 DOI: 10.1016/j.vaccine.2021.11.094  0.027
2012 Hirschhäuser C, Parker JS, Perry MWD, Haddow MF, Gallagher T. Spiro-fused pyrrolidine, piperidine, and oxindole scaffolds from lactams Organic Letters. 14: 4846-4849. PMID 22946703 DOI: 10.1021/ol302176z  0.027
2013 Parker JS, Lu M, Park H, Sivananthan A, Bloch E, Griffith Z, Johansson LA, Rodwell MJW, Coldren LA. Highly-stable integrated InGaAsP/InP mode-locked laser and optical phase-locked loop Ieee Photonics Technology Letters. 25: 1851-1854. DOI: 10.1109/Lpt.2013.2277865  0.027
2013 Mestichelli P, Scott MJ, Galloway WR, Selwyn J, Parker JS, Spring DR. Concise copper-catalyzed synthesis of tricyclic biaryl ether-linked aza-heterocyclic ring systems. Organic Letters. 15: 5448-51. PMID 24134806 DOI: 10.1021/ol4025259  0.027
2012 Parker JS. Developing the philosophy of recovery in South African mental health services African Journal of Psychiatry (South Africa). 15: 417-419. PMID 23160615 DOI: 10.4314/ajpsy.v15i6.51  0.027
2015 Tchabanenko K, Chesworth R, Parker JS, Anand NK, Russell AT, Adlington RM, Baldwin JE. Retraction notice to "Biomimetic approach to Galbulimina type I alkaloids" [Tetrahedron 61 (2005) 11649-11656] Tetrahedron. DOI: 10.1016/J.Tet.2015.12.025  0.026
2013 Sivananthan A, Park Hc, Lu M, Parker JS, Bloch E, Johansson LA, Rodwell MJ, Coldren LA. Integrated linewidth reduction of a tunable SG-DBR laser Cleo: Science and Innovations, Cleo_si 2013. CTu1L.2.  0.025
2014 De Smet S, Parker JS, Herman JFC, Noomen R. Preliminary mission design for a crewed earth-Mars flyby mission using solar electric propulsion (SEP) Advances in the Astronautical Sciences. 152: 2247-2265.  0.024
2002 Parker J. Asante Identities: History and modernity in an African village 1850–1950, by T. C. McCaskie. Edinburgh: Edinburgh University Press for the International African Institute, London, and Bloomington, IN: Indiana University Press, 2000. ix + 277 pp. £14.95 paperback. ISBN 0‐7486‐1510‐5 African Affairs. 101: 119-120. DOI: 10.1093/afraf/101.402.119  0.024
2014 Livny E, Parker JS, Van Der Kaaij M, Haasdijk ED, Van Der Wees J, Bruinsma M, Melles GRJ. Postmortem ultrastructural analysis of a cornea transplanted with descemet membrane endothelial keratoplasty Cornea. 33: 790-794. PMID 24977986 DOI: 10.1097/ICO.0000000000000156  0.023
2014 Parker JS, Anderson RL. Low-Energy Lunar Trajectory Design Low-Energy Lunar Trajectory Design. 1-396. DOI: 10.1002/9781118855065  0.023
2011 Lambert J, Greer PB, Menk F, Patterson J, Parker J, Dahl K, Gupta S, Capp A, Wratten C, Tang C, Kumar M, Dowling J, Hauville S, Hughes C, Fisher K, et al. MRI-guided prostate radiation therapy planning: Investigation of dosimetric accuracy of MRI-based dose planning. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 98: 330-4. PMID 21339009 DOI: 10.1016/j.radonc.2011.01.012  0.023
2013 Parker JS. Corporate crime, overcriminalization, and the failure of american public morality The American Illness: Essays On the Rule of Law. 407-431.  0.022
2015 Stasulli NM, Eichelberger KR, Price PA, Pechous RD, Montgomery SA, Parker JS, Goldman WE. Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague Mbio. 6.  0.022
2013 Leonard JM, Parker JS, Anderson RL, McGranaghan RM, Fujimoto K, Born GH. Supporting crewed lunar exploration with liaison navigation Advances in the Astronautical Sciences. 149: 327-340.  0.022
2013 Sivananthan A, Park HC, Lu M, Parker JS, Bloch E, Johansson LA, Rodwell MJ, Coldren LA. Monolithic Linewidth narrowing of a tunable SG-DBR laser Optical Fiber Communication Conference, Ofc 2013. OTh3I.3.  0.022
2012 Lin CH, Thibeault BJ, Zheng Y, Parker JS, Rodwell MJW, Coldren LA. Ultra-compact intra-cavity contacts for multi-terminal VCSEL power enhancement 2012 Ieee Photonics Conference, Ipc 2012. 116-117. DOI: 10.1109/IPCon.2012.6358516  0.021
2012 Armstrong GSJ, Parker JS, Taylor KT. Double-electron above-threshold ionization resonances as interference phenomena Journal of Physics: Conference Series. 388. DOI: 10.1088/1742-6596/388/3/032057  0.021
2015 Sun J, Dowling JA, Pichler P, Parker J, Martin J, Stanwell P, Arm J, Menk F, Greer PB. Investigation on the performance of dedicated radiotherapy positioning devices for MR scanning for prostate planning. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 16: 4848. PMID 26103166 DOI: 10.1120/jacmp.v16i2.4848  0.02
2013 Lu M, Park HC, Parker JS, Bloch E, Sivananthan A, Griffith Z, Johansson LA, Rodwell MJ, Coldren LA. A heterodyne optical phase-locked loop for multiple applications Optical Fiber Communication Conference, Ofc 2013. OW3D.1.  0.02
2016 Parker JS, DeNiro J, Ivey ML, Doohan D. Are small and medium scale produce farms inherent food safety risks? Journal of Rural Studies. 44: 250-260. DOI: 10.1016/j.jrurstud.2016.02.005  0.02
2015 Hesar SG, Parker JS, Leonard JM, McGranaghan RM, Born GH. Lunar far side surface navigation using Linked Autonomous Interplanetary Satellite Orbit Navigation (LiAISON) Acta Astronautica. 117: 116-129. DOI: 10.1016/j.actaastro.2015.07.027  0.019
2011 Hatton JA, Greer PB, Tang C, Wright P, Capp A, Gupta S, Parker J, Wratten C, Denham JW. Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised tomography scans. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 98: 162-8. PMID 21295873 DOI: 10.1016/j.radonc.2011.01.006  0.017
2014 Hesar S, Parker JS, McGranaghan RM, Leonard JM, Fujimoto K, Born GH. Application of LiAISON orbit determination architecture in navigating a rover on the lunar surface Advances in the Astronautical Sciences. 150: 553-571.  0.016
2013 Parker JS. Equality of opportunity in veterinary medicine Journal of the American Veterinary Medical Association. 243: 1677-1678. PMID 24443763  0.016
2015 Herman JFC, Parker JS. Low-energy, low-thrust transfers between earth and distant retrograde orbits about the moon Advances in the Astronautical Sciences. 154: 525-536.  0.016
2014 Dietrich AB, Parker JS, Born G. Far-side lunar ascent trajectory design to Earth-moon l2 orbit Advances in the Astronautical Sciences. 150: 2727-2742.  0.016
2012 Moore LR, Lysaght MA, Nikolopoulos LAA, Parker JS, Van Der Hart HW, Taylor KT. Time delay between photoemission from the 2p and 2s subshells of Neon atoms Journal of Physics: Conference Series. 388. DOI: 10.1088/1742-6596/388/3/032044  0.016
2021 Ellingson KD, Gerald JK, Sun X, Hollister J, Lutrick K, Parker J, Rivers P, Beitel SC, Baccam Z, Lamberte JM, Grant L, Kim E, Bhattarai R, Komatsu K, Meece J, et al. Incidence of SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential Workers During a Prevaccination COVID-19 Surge in Arizona. Jama Health Forum. 2: e213318. PMID 35977166 DOI: 10.1001/jamahealthforum.2021.3318  0.015
2014 Davis KE, Parker JS, Deilami M, Butcher EA. Improved transfers to Earth-Moon L3 halo orbits Advances in the Astronautical Sciences. 152: 543-557.  0.014
2015 Parker JS. Affective states of animals Journal of the American Veterinary Medical Association. 246: 835.  0.012
2013 Sivananthan A, Park Hc, Lu M, Parker JS, Bloch E, Johansson LA, Rodwell MJ, Coldren LA. Integrated linewidth reduction of a tunable SG-DBR laser Cleo: Science and Innovations, Cleo_si 2013. CTu1L.2.  0.012
2014 Welch CM, Parker JS. Mission considerations for direct transfers to a distant retrograde orbit Advances in the Astronautical Sciences. 151: 61-71.  0.011
2014 Parker JS. Letter to the Editor Journal of the American Veterinary Medical Association. 244: 646. DOI: 10.2460/javma.244.6.646  0.011
2012 Wallace MS, Parker JS, Strange NJ, Grebow D. Orbital Operations for Phobos and Deimos Exploration Aiaa/Aas Astrodynamics Specialist Conference 2012. DOI: 10.2514/6.2012-5067  0.01
2024 Parker J. Extract from a Lecture on the Rights and Liabilities of the Physician and Surgeon. Western Journal of Medicine and Surgery. 3: 217-219. PMID 38211231  0.01
2022 Parker J. The Family. Hall's Journal of Health. 13: 248-250. PMID 36487946  0.01
2016 Parker JS. Conveying the importance of veterinary dental health Journal of the American Veterinary Medical Association. 248: 485-486.  0.01
2015 Wragg J, Parker JS, Van Der Hart HW. Double ionization in R -matrix theory using a two-electron outer region Physical Review a - Atomic, Molecular, and Optical Physics. 92. DOI: 10.1103/PhysRevA.92.022504  0.01
2015 Wragg J, Parker JS, Van Der Hart HW. Application of R-Matrix with Time-dependence Theory to Double Ionisation Using a 2-electron Outer Region Journal of Physics: Conference Series. 635. DOI: 10.1088/1742-6596/635/9/092051  0.01
2015 De Smet S, Parker JS, Herman JFC, Noomen R. Mission design for a crewed earth-Venus-mars flyby mission using solar electric propulsion Advances in the Astronautical Sciences. 154: 501-512.  0.01
2014 Parker JS. More on personhood for chimps [2] Journal of the American Veterinary Medical Association. 244: 894-895. PMID 24818309 DOI: 10.2460/javma.244.8.894  0.01
2014 Parker JS. People are people Journal of the American Veterinary Medical Association. 244: 646. PMID 24568102  0.01
2014 Leonard JM, Parker JS, Born GH. Uncertainty mapping and navigation techniques for crewed missions in libration orbits Aiaa/Aas Astrodynamics Specialist Conference 2014.  0.01
2014 Parker JS, Leonard JM, Anderson RL, Born GH. LiAISON-supplemented navigation of a crewed vehicle in a lunar halo orbit Advances in the Astronautical Sciences. 150: 1113-1131.  0.01
2013 Parker JS. Veterinary applicants Journal of the American Veterinary Medical Association. 243: 617-618. PMID 24133706 DOI: 10.2460/javma.243.5.617  0.01
2013 Parker JS, Allen RR, Lund C. Are we training our psychiatrists adequately as public mental health practitioners? South African Journal of Psychiatry. 19: 2-3. DOI: 10.7196/SAJP.431  0.01
2013 Sivananthan A, Park HC, Lu M, Parker JS, Bloch E, Johansson LA, Rodwell MJ, Coldren LA. Monolithic Linewidth narrowing of a tunable SG-DBR laser Optical Fiber Communication Conference, Ofc 2013. OTh3I.3.  0.01
2013 Parker JS, Leonard JM, Fujimoto K, McGranaghan RM, Born GH, Anderson RL. Navigating a crewed lunar vehicle using LiAISON Advances in the Astronautical Sciences. 148: 1921-1939.  0.01
2012 Parker JS, Anderson RL, Born GH, Fujimoto K, Leonard JM, McGranaghan RM. Navigation between geosynchronous and lunar L1 orbiters Aiaa/Aas Astrodynamics Specialist Conference 2012. DOI: 10.2514/6.2012-4878  0.01
2012 Leonard JM, McGranaghan RM, Fujimoto K, Borny GH, Parker JS, Andersonx RL. LiAISON-supplemented navigation for geosynchronous and lunar L1 orbiters Aiaa/Aas Astrodynamics Specialist Conference 2012. DOI: 10.2514/6.2012-4664  0.01
2012 Robinson DJ, Parker JS, Moore LR, Taylor KT. Calculation of the harmonic spectrum for one and two-electron atoms in two-colour laser fields Journal of Physics: Conference Series. 388. DOI: 10.1088/1742-6596/388/3/032056  0.01
2012 Lysaght MA, Moore LR, Nikolopoulos LAA, Parker JS, Hart HWVD, Taylor KT. The RMT method for describing many-electron atoms in intense short laser pulses Journal of Physics: Conference Series. 388. DOI: 10.1088/1742-6596/388/1/012027  0.01
2008 Parker J. STEPHAN F. MIESCHER. Making Men in Ghana. Bloomington: Indiana University Press. 2005. Pp. xxxii, 323. $65.00 The American Historical Review. 113: 291-291. DOI: 10.1086/ahr.113.1.291  0.01
1993 Panton RW, Sulewski ME, Parker JS, Panton PJ, Stark WJ. Surgical management of subluxed posterior-chamber intraocular lenses. Archives of Ophthalmology (Chicago, Ill. : 1960). 111: 919-26. PMID 8328933 DOI: 10.1001/archopht.1993.01090070037015  0.01
Hide low-probability matches.